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RESUME (français) 
Le mode de coordination parmi les différentes molécules qui 
régulent la migration reste très peu connu. Ce travail traite de deux voies 
de transduction régulant la migration : la voie Rac1/WRC (Wave 
Regulatory Complex) qui contrôle la formation du réseau d’actine au 
front des cellules migrantes, et la voie RalB/exocyst, dont les 
mécanismes moléculaires de son implication dans la motilité cellulaire 
étaient inconnus au début de cette thèse. Rac1 et RalB sont des petites 
protéines G des familles Rho et Ras, respectivement. Les complexes WRC 
et exocyst sont leurs effecteurs directs. 
Au cours de la recherche de connexions entre l’exocyst et des 
régulateurs de la migration, nous avons trouvé que deux sous-unités de 
l’exocyst, Exo70 et Sec6, interagissent directement in vitro avec Abi et 
Cyfip, respectivement, deux sous unités du WRC. De plus, nous avons 
trouvé que les sous-unités de l’exocyst peuvent interagir in vitro avec le 
WRC entier. Nous avons également montré que ces deux complexes 
s’associent in vivo. Sur le plan fonctionnel, l’exocyst est requis pour le 
positionnement du  complexe WRC au front des cellules migrantes. 
D’autre part, nous avons également trouvé que deux autres sous-
unités de l’exocyst Sec8 and Exo84, interagissent avec  SH3BP1 (une 
RhoGAP) en double hybride et en co-immunoprécipitation. SH3BP1 se 
localise au front des cellules migrantes, et cette localisation dépend de 
l’exocyst. De façon intéressante, in vivo, la voie RalB/exocyst/SH3BP1 
cible spécifiquement Rac1, et non Cdc42. Grâce à plusieurs approches, 
nous concluons que SH3BP1 est requis pour inactiver Rac1 au front. 
Dans notre modèle nous proposons que RalB/exocyst règulerait la 
migration cellulaire en véhiculant au front de migration deux éléments 
majeurs de la signalisation de Rac1 : son complexe effecteur WRC, qui 
stimule la nucléation de filaments d’actine et son régulateur négatif 
SH3BP1, une GAP qui promeut l’inactivation et le cycle GDP/GTP de 
Rac1. En conclusion, ce travail fournit de nouvelles connexions 
moléculaires et fonctionnelles entre l’exocytose polarisée et la dynamique 
de l’actine au cours de la motilité cellulaire. 
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RIASSUNTO  (italiano) 
I meccanismi di coordinazione tra le varie molecule che regolano 
la migrazione restano poco conosciuti. Questo lavoro tratta di due vie di 
segnale che regolano la migrazione: la via Rac1/WCR (Wave Regulatory 
Complex) che controlla la formazione della rete di actina al fronte delle 
cellule migranti; e la via RalB/exocyst, i cui meccanismi molecolari alla 
base della sua implicazione nella migrazione cellulare erano ignoti 
all’inizio di questa tesi. Rac1 e RalB fanno rispettivamente parte delle 
famiglie Rho e Ras delle piccole proteine G. I complessi WRC ed exocyst 
sono i loro effettori diretti. Ricercando possibile connessioni tra l’exocyst 
e le molecole regolatrici della migrazione, abbiamo trovato che due 
subunità dell’exocyst, Exo70 e Sec6, interagiscono direttamente in vitro 
con Abi e Cyfip, che sono due subunità del complesso WRC. Inoltre 
abbiamo trovato che le subunità dell’exocyst possono interagire in vitro 
con il complesso WRC intero, contenente tutti i suoi componenti. 
Abbiamo mostrato che questi due complessi sono associati anche in vivo. 
Dal punto di vista funzionale, l’exocyst è necessaria per posizionare il 
complesso WRC al fronte delle cellule migranti. D’altra parte abbiamo 
trovato che due altre subunità dell’exocyst, Sec8 e Exo84, interagiscono 
con SH3BP1 (una proteina RhoGAP) grazie alla tecnica del doppio-ibrido 
e per co-immunoprecipitazione. SH3BP1 si trova al fronte delle cellule 
migranti; questa sua localizzazione dipende dalla presenza dell’exocyst. 
E’ interessante il fatto che, in vivo, la via RalB/exocyst/SH3BP1 ha come 
bersaglio Rac1, e non Cdc42. Combinando diversi approcci abbiamo 
potuto concludere che SH3BP1 è necessaria all’inattivazione di Rac1 al 
fronte. 
Nel nostro modello proponiamo che RalB/exocyst regola la 
migrazione cellulare trasportando al fronte di migrazione due elementi 
chiave delle vie di segnale di Rac1: il suo complesso effettore WRC, che 
stimola la nucleazione di filamenti di actina , e il suo regolatore negativo 
SH3BP1, una GAP che promuove l’inattivazione e il ciclo GDP/GTP di 
Rac1. In conclusione, questo lavoro ha messo in evidenza nuove 
connessioni molecolari e funzionali tra l’esocitosi polarizzata e le 
dinamiche d’actina durante la migrazione cellulare. 
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SUMMARY (English) 
Very little is known about the coordination and the integration 
among the different regulators of the motility process. This work deals 
with two migration-regulatory pathways: the Rac1/WRC (Wave 
Regulatory Complex) pathway that drives the formation of the actin 
polymerization network at the front of motile cells; and RalB/exocyst 
pathway for which the molecular mechanisms underlying its implication 
in cell motility were still largely unknown at the beginning of this thesis. 
Rac1 and RalB are small GTPases of the Rho and Ras family, 
respectively. WRC and exocyst complexes are their direct effectors.  
In searching for connections between the exocyst and migration 
regulators, we found that two subunits of the exocyst, Exo70 and Sec6, 
interact directly in vitro with two subunits of the WRC, Abi and Cyfip, 
respectively. Moreover, we found that exocyst subunits can interact in 
vitro with the whole fully-assembled WRC complex. We also showed that 
these two complexes associate in vivo. Functionally, the exocyst was 
required for WRC complex positioning at the front of migrating cells. 
On the other hand, we also found that two other subunits of the 
exocyst, Sec8 and Exo84, interact with SH3BP1 (a RhoGAP protein) by 
two-hybrid assay and by co-immunoprecipitation. SH3BP1 localizes at 
the leading edge and this localization is dependent on the exocyst. 
Interestingly, in vivo, the RalB/exocyst/SH3BP1 pathway specifically 
targets Rac1, and not Cdc42. By a combination of approaches we 
concluded that SH3BP1 is required to inactivate Rac1 at the front.  
In our model we propose that RalB/exocyst regulates cell 
migration by driving to the leading edge two key signaling elements of 
the Rac1 pathway: its effector WRC, that stimulates actin filament 
nucleation, and its negative regulator SH3BP1, a GAP promoting Rac1 
inactivation and GDP/GTP cycling. In conclusion, this work provides 
novel molecular and functional links between polarized exocytosis and 
actin dynamics during cell motility.   
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ABBREVIATIONS 
CaM               Calmodulin  
DE-cadherin   Drosophila Epithelial Cadherin 
bFGF              Basic fibroblast growth factor 
FLIM               Fluorescence-lifetime imaging microscopy 
GAP          GTPase activating protein 
GDP               Guanosine diphosphtae 
GEF          Guanosyl exchange factor 
HEK-HT          Human embryonic kidney cell line 
HGF               Hepatocyte growth factor 
IGF-1              Insulin-like growth factor 1  
NPF                Nucleation Promoting Factor  
PH                  Plecstrine Homology 
PP2A              Phosphatase 2A  
PLC          Phospholipase C 
PLD          Phospholipase D 
PP2A          Protein phosphatase type 2A 
RAL          RAS like 
RAL-BP1         Ral binding protein 
RALGDS         Ral Guanine nucleotide dissociation 
stimulator 
RNAi            RNA interference 
SNARE           SNAP Receptor proteins  
VCA domain   Verprolin homology, Cofilin homology, and 
Acidic region 
WASP             Wiskott-Aldrich Syndrome Protein 
WAVE             WASP family Verprolin-homologous  
ZONAB          ZO-1-associated nucleic acid-binding 
protein 
WRC               Wave regulatory complex 
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1. RAL 
 
1.1. RAL GTPases 
 
1.1.1. Discovery 
Exploration of Ras functions in yeast provided the first 
evidence pointing to the importance of Ras as a hub in signal 
transduction (Van Aelst et al., 1994).  This concept has been 
extended to mammalian cells, where Ras proteins were found to 
mediate the transduction of various signaling pathways emanating 
from plasma membrane receptors by directly associating with at 
least three major signal transducers: Raf, PI3Kinase and RalGEFs 
(Downward, 2003). Mutations in the effector domain of Ras 
enabled to dissect the contribution of each of these effectors and 
transduction patwhays to oncogenic Ras functions.  
Ral proteins (Ras like) are small G proteins belonging to Ras 
superfamily. In addition they act downstream of Ras since 
RalGEFs, direct effectors of Ras, are also direct activators of Ral. 
They share the biochemical properties typical of all GTPases: 
cycling between a non active GDPlinked form, to an active GTP-
linked form. Ral-encoding genes were isolated from a cDNA library 
of immortalized simian B-lymphocytes, by using a degenerated 
probe specific to Ras family domains (Chardin and Tavitian, 1986).  
 
1.1.2. Structure 
RalGTPases exist in all multicellular organisms (one gene in 
fly, two in humans, and four in zebrafish). In mammalian cells, 
two different genes encode RalA and RalB proteins; they are 
located on 7p15-p13 and 2cen-q13 respectively (Chardin and 
Taviatian, 1989). RalA and RalB are monomeric proteins of 206 
aminoacids, with a predicted molecular weight of 23.5 KDa. RalA 
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and RalB show 85% of homology. In fact, these two proteins are 
100% identical over the two “switch” regions (Figure I1).  
Despite this structural homology, RalA and RalB clearly 
have different functions as it will be discussed later in this 
manuscript.  
The main domain of Ral is the GTPase domain (residues 12-
178). It contains four GTP binding motifs, which are conserved in 
all small GTPases. Within the GTPase domain, two regions called 
“switch” (residues 40-48 and 70-78) change conformation upon 
GTP binding and mediate effector binding. Effectors bind to a 
single switch or stretch across both. At the N-terminal, an 
extension of 11 amino acids is supposed to mediate interactions 
with phospholipase D (PLD) or phospholipase C-δ1 (PLC-δ1); at the 
C-terminal tail there is a short calmodulin-binding domain (Sidhu, 
Clough, & Bhullar, 2005).  
The major differences between RalA and RalB is in the C-
terminal region between residue 181 in RalB (residue 180 in RalA) 
and the four C-terminal residues that comprise the site of 
prenylation necessary for membrane association (Kinsella et al., 
1991; Hancock et al., 1989; Hancock et al., 1990). This region is 
called the hypervariable region. It contains two phosphorylation 
sites in RalA (Ser183 and Ser 194) and one phosphorylation site in 
RalB (Ser198). The differences in the “hypervariable region” of RalA 
and RalB may be responsible for the different subcellular 
distribution of RalA and RalB. RalA localizes at the 
plasmamembrane and endosome, whereas RalB is present 
exclusively at the plasma membrane (Shipitsin and Feig, 2004). 
 
The solutions of the various Ral crystal structure were 
instrumental to help defining the mechanisms of its regulation. 
Crystal structures of active (bound to the GTP-analogous GppNHp) 
and inactive (bound to GDP) RalA conformations were published 
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(Nicely et al., 2004), as well as the structure of the complex 
between active RalA and a Ral-binding domain from its Sec5 
effector (Fukai et al., 2003). 
The comparison between active and inactive forms suggests 
nucleotide-dependent switch mechanism in RalA to bind Sec5. 
There are two putative sites for RalA-Sec5 interaction: the first one 
is adjacent to switch I and the second one is modulated by switch 
II and obstructed in Ral inactive form (Fukai et al., 2003) 
The crystal structure of the complex formed by active RalB 
and the Ral-binding domain of another effector, RalBP1 (Fenwick 
et al., 2009) revealed somedifferences with respect to the RalA-
Sec5 complex, in that both switch regions directly contact the 
RalBP1 effector. 
 
 
 
 
Figure I1: a) Alignment of amino acid sequence of RalA and 
RalB, from rats and humans. Identical amino acids (blue), 75% 
identity between the four sequences (green) and 50% or less (brown). 
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b) RalA domain primary structure. RalA contains 206 amino acids, 
with four motifs for GTP binding and hydrolysis (labelled I–IV). The 
switch regions of RalA are indicated (switch I-II). The N-terminal 11 
amino acids bind PLD1 and PLC-δ1. The effector binding domain is 
represented in green. The C-terminus domain contains Calmodulin 
(CaM) binding domain, the phosphorylation site for Aurora-A kinase at 
Ser-194 (RalA only) and the site for post-translational lipid 
modification (van Dam and Robinson, 2006). 
 
 
1.2. REGULATION  
Like other small GTPases, Ral proteins act as molecular 
switches and timers that cycle between inactive guanosine 
diphosphate (GDP)-bound and active guanosine triphosphate 
(GTP)-bound states. In GTP-bound state, they have higher affinity 
for downstream effectors through which they are controlling 
different biological processes.  
Activation of GTPases is catalyzed by GEFs (Guanosyl 
Exchange Factor). The interaction of GTPase with GEF destabilizes 
the GTPase-GDP complex and leads to the dissociation of GDP. 
This is followed by association of GTP because of the fact that the 
intracellular concentration of GTP is 10-times higher than the 
concentration of GDP. Inactivation of GTPases requires hydrolysis 
of the bound GTP to GDP. The intrinsic catalytic activities of Ral 
proteins are weak and GTP hydrolysis is enhanced by the 
intervention of GAPs (GTPase Activating Proteins) (Figure I2). 
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Figure I2: The cycle of Ral GTPases. Inactive Ral is loaded with 
GDP. RalGEF induce the release of GDP followed by GTP loading, 
which activates Ral. Hydrolysis of GTP is mediated by RalGAPs, 
which inactivates Ral (Bodemann and White, 2008). 
 
 
1.2.1. Regulation by RalGEFs 
Six RalGEFs have been identified in human: RalGDS, Rgl1, 
Rgl2, Rgl3, RalGPS1 and RalGPS2. They can be classified in two 
groups: RalGDS, Rgl1, Rgl2, Rgl3 have a C-terminal Ras 
Association domain (RA), and can be directly activated by Ras; 
RalGPS1 and RalGPS2 do not have a RA domain, therefore they 
activate Ral GTPases independently of Ras (van Dam and 
Robinson, 2006; Bodemann and White, 2008) (Figure I2A).  
Upon binding a RalGEF, the binary Ral-GDP complex 
becomes a trimeric GEF-Ral-GDP complex, in which the GEF 
catalyses the release of the GDP, producing the nucleotide-free 
GEF-Ral complex; this series of reactions is reversed by rebinding 
of a nucleotide, predominantly GTP, leading to the active Ral-GTP 
complex (Vetter and Wittinghofer, 2001). 
 
17 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure I2A: he RalGEF family and their regulatory cues. An 
important aspect involves relief of   autoinhibitory interactions of 
amino-terminal and/or C-terminal regulatory motifs (indicated in 
the figure in  yellow and red, respectively) with the catalytic domain 
(indicated in green). (a) In the case of human retinal G-protein 
coupled receptor (RGR), N-terminal truncation mutants found in 
lymphoma exhibit cell transformation activity in cell culture and 
transgenic expression in thymocytes. (b) Consistently with this 
regulatory  motif, 3-phosphoinositide-dependent protein kinase 
1  (PDPK1) associates with the N terminus of RALGDS to  relieve 
autoinhibition of catalytic activity in response to  epidermal growth 
factor receptor activation75,76.  RALGDS is also a direct effector of 
Ras–GTP through the  C-terminal Ras association (RA) domain. (c) 
Finally, the RALGPS2 PXXP–PH domains have dominant inhibitory 
activity (c), decreasing Ral–GTP accumulation by 50% when 
expressed in HEK 293 cells (Bodemann and White, 2008). 
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Box 2 | The RalGEF family and their regulatory cues
Ral GTPases are engaged in response to a broad variety 
of mitogenic, trophic and hormonal signals by a diverse 
group of guanyl nucleotide exchange factors (GEFs) that 
fall into two major groups: those that can be directly 
Ras-responsive through a carboxy-terminal Ras-binding 
domain (RALGDS, RGL1, RGL2), and those that are 
apparently mobilized by phosphatidylinositol  second 
messengers through a C-terminal pleckstrin homology 
(PH) domain (RALGPS1, RALGPS2)4. Virtual expression 
profiling, based on UniGene annotation of expressed 
sequence tags, suggests that all five members are 
broadly expressed in both normal tissues and tumours. In 
addition, human retinal G-protein coupled receptor 
(RGR) has promiscuous exchange factor activity towards 
Ras G-protein family members, including Ral73. The 
mechanistic basis of RalGEF activation is poorly 
understood; however, a series of observations suggest  
that one important aspect involves relief of 
autoinhibitory interactions of amino-terminal and/or  
C-terminal regulatory motifs (indicated in the figure in 
yellow and red, respectively) with the catalytic domain 
(indicated in green). In the case of RGR (a), N-terminal 
truncation mutants found in lymphoma exhibit  cell 
transformation activity in cell culture73 and transgenic 
expression in thymocytes of p15INK4b (also known as 
Cdkn2b)-defective mice induce a high incidence of 
thymic lymphomas74. Consistently with this regulatory 
motif, 3-phosphoinositide-dependent  protein kinase 1 
(PDPK1) associates with the N terminus of RALGDS to 
relieve autoinhibition of catalytic activity in response to 
epidermal growth factor receptor activation75,76. 
RALGDS is also a direct effector of Ras–GTP through the 
C-terminal Ras association (RA) domain (b). Ras-dependent  derepression of intramolecular autoinhibitory interactions is 
an emerging theme among Ras–effector relationships2. Finally, the RALGPS2 PXXP–PH domains have dominant inhibitory 
activity (c), decreasing Ral–GTP accumulation by 50% when expressed in HEK 293 cells. The sensitivity of RalGPS2 activity 
to wortmannin suggests that this domain is responsive to phosphatidyl inositol kinase activity77. Intriguingly, a collection 
of RalGEF mutations have been identified in human tumours that are distributed among sequences encoding both 
catalytic and regulatory regions (TABLE 1). Activating mutations in the Ras exchange factor SOS1 cause a distinctive form 
of Noonan Syndrome, a developmental disorder characterized by facial dysmorphia, short  stature, congenital heart  
defects and skeletal anomalies78.These mutations cluster in or near the N-terminal GEF domain which is important in 
maintaining the protein in its autoinhibited form. The functional consequences of the identified RalGEF mutations, if any 
exist, remain to be determined. PtdIns, phosphatidyl inositol; SH3, SRC homology 3.
REVIEWS
CANCER 135
© 2008 Nature Publishing Group 
18 
 
Ras-dependent activation 
Ras can activate Ral via various mechanisms. 
Several works have demonstrated that Ras proteins activate 
Ras-dependent RalGEFs, at least in part, by relocalizing them to 
their target, the Ral GTPases: RalGDS, Rgl1, Rgl2 and Rgl3 bind to 
activated Ras through their RA domain and consequently they are 
translocated to the plasma membrane where they can stimulate 
the GDP to GTP exchange on Ral (Huang et al., 1998; Hofer et 
al., 1998). 
The activation of RalGEFs by Ras might also occur through 
other Ras effectors, thePI3-Kinases: the PI3-K-dependent kinase 1 
(PDK1) interacts with the N-terminal domain of RalGDS, relieves 
its auto-inhibitory effect and enhances GEF activity on its target 
Ral; this PDK1 function is not dependent upon its kinase activity 
(Tian et al., 2002).  
The regulatory mechanisms of Ras-dependent RalGEFs are 
still poorly investigated. For example, a recent study suggests that 
phosphorylation of Rgl2 by CyclinD1-Cdk4 complex may stimulate 
its GEF activity (Fernandez et al., 2011). 
 
Ras-independent activation 
RalGPS1 and RalGPS2 share the core catalytic domain of 
other RalGEFs, but don’t have a RA domain. At the C-terminal, 
they have a PH (Plecstrine Homology) domain suggested to be 
necessary for membrane targeting. They have a proline-rich motif, 
which allows interaction with SH3-containing adapter proteins 
Grb2 and Nck.  The interaction with these adaptors likely 
contributes to RalGPS regulation (Rebhun et al., 2000). 
RalGDS can also interact with β-arrestins. In leukocytes, 
under basal conditions, RalGDS is associated with β-arrestins in 
the cytosol. fMLP (formyl-Met-Leu-Phe) receptor stimulation 
recruits β-arrestin–RalGDS protein complexes to the plasma 
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membrane. β-arrestin binding to the fMLP receptor is followed by 
the release of RalGDS and results in Ras-independent activation of 
Ral. This mechanism has been implicated in cytoskeletal 
reorganization required for cell migration in response to 
chemoattractant stimulus (Bhattacharya et al., 2002). 
Another way to activate Ral by a Ras-independent pathway 
is through modulation of Ca2+. Activation of PLC increases 
intracellular Ca2+ level and was proposed to promote Ral 
activation, possibly via the binding of calmodulin (CaM) to Ral, 
(Hofer et al., 1998). Both RalA and RalB interact specifically in 
vitro and in vivo with calmodulin. Both RalA and RalB have a 
calcium dependent CaM-binding site in their C-terminal region, 
and a calcium independent binding site in their N-terminal region. 
Moreover, in vitro Ral-GTP pull-down experiments demonstrated 
that thrombin-induced activation of Ral in human platelets 
requires calmodulin, suggesting that calmodulin regulates Ral 
activation in human platelets (Clough et al., 2002). 
 
1.2.2. Regulation by RalGAPs 
The existence of a protein with a Ral-specific GAP activity 
was biochemically demonstrated using the cytosolic fraction of 
brain and testis (Emkey et al., 1991). It took long time to identify 
the coding genes because it turned out that the RalGAPs are 
multiprotein complexes, which require heterodimerization for their 
GAP activity. The first proteins with RalGAP activity were identified 
in 2009 and named RalGAP1 and RalGAP2. They are large 
heterodimeric complexes, each composed of a catalytic α1 (240 
kDa) or α2 (220 kDa) subunit and a common β subunit (170 kDa) 
(Shirakawa et al., 2009). Akt2, also known as PKB beta, 
phosphorylates RalGAP2 upon insulin stimulation. This 
phosphorylation inhibits RalGAP2 activity and therefore activates 
Ral GTPases (Chen et al., 2011). Since Akt2 acts down-stream of 
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the Ras-effector PI3-kinases, this axis may define an additional 
mechanism by which Ras can activate Ral proteins.  
 
1.2.3. Regulation by phosphorylation 
Phosphorylation of RalA on Ser183 and on Ser194 by 
AuroraA, promotes its activation, its translocation from plasma 
membrane and the activation of the effector protein RalBP1 (Lim et 
al., 2010). PP2A Abeta, a well known tumor suppressor, 
dephosphorylates RalA at these sites Ser183 and Ser194, 
inactivating RalA and abolishing its transforming function. It was 
proposed that PP2A Abeta suppresses transformation of 
immortalized human cells by regulating the function of RalA 
(Sablina et al., 2007).  
Phosphorylation of RalB on Ser198 by PKC was shown in 
vitro and in vivo. In human bladder carcinoma cells, PMA (phorbol 
ester [phorbol 12-myristate 13-acetate]) treatment induced S198 
phosphorylation of RalB. This phosphorylation is necessary for 
RalB translocation from the plasma membrane to perinuclear 
regions, as well as for actin cytoskeletal organization, anchorage-
independent growth, cell migration and lung metastasis (Wang et 
al., 2010).  
These observations showing that RalA and RalB are 
phosphorylated by different kinases may contribute to their 
different biological functions.  
 
1.3. EFFECTORS 
 
1.3.1. Exocyst 
The exocyst complex consists of eight subunits named Sec3, 
Sec5, Sec6, Sec8, Sec10, Sec15, Exo70 and Exo84, and was first 
identified in the secretory pathway of budding Yeast (Novick et al., 
1980; TerBush et al., 1996; Finger and Novick, 1998). Exocyst 
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complex, which is conserved from yeast to humans, is required for 
polarized secretion by controlling the docking of intracellular 
vesicles to specific sites of the plasma membrane (He and Guo, 
2009). The mammalian subunits are called EXOCs (exocyst 
complex components) 1-8 (figure I3A); however the yeast 
nomenclature is still currently used (figure I3).  
 
Yest Mammalian 
SEC3 EXOC1 
SEC5 EXOC2 
SEC6 EXOC3 
SEC8 EXOC4 
SEC10 EXOC5 
SEC15 EXOC6 
EXO70 EXOC7 
EXO84 EXOC8 
 
Figure I3A: Yest and mammalian nomenclature of exocyst 
subunits.  
 
Two exocyst subunits, Sec5 and Exo84, interact with the 
active form of Ral GTPases. Thus, they are direct effectors of RalA 
and RalB.  The functions of the Ral-Exocyst are not fully 
understood, but RalA silencing experiments suggested that RalA is 
required for the assembly of the full octameric complex 
(Moskalenko et al., 2002; Moskalenko et al., 2003).  
The functional aspects of exocyst will be presented later in 
the manuscript (Chapiter 2.3). 
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Figure I3: RalGTPases promote exocyst assembly. This 
model proposes that RalGTPases interact with Sec5 and Exo84 
to assemble the exocyst complex by combining two 
subcomplexes: the Exo84 subcomplex on secretory vesicles and 
the Sec5 subcomplex on plasma membrane target sites. Other 
GTPases can also associate with exocyst subunits, as indicated 
by the arrows, and might participate in dynamic regulation of 
this secretory machinery (Camonis and White, 2005). 
 
1.3.2. RalBP1 
RalBP1 (Ral Binding Protein 1), also known as RLIP76, was 
the first identified effector of Ral GTPases. It interacts with the 
active form of RalA and RalB (Cantor et al., 1995; Jullien-Flores et 
al., 1995). RalBP1 contains a Ral binding domain and a Rho GAP 
domain, which has a GAP activity on Rac and Cdc42 (Jullien-
Flores et al., 1995). RalBP1 interacts also with AP2 (adaptor 
protein 2, adaptor protein for clathrin binding to membrane), 
during transferrin and EGF receptor endocytosis; and with POB1 
(RalBP1-binding protein, regulates receptor-mediated endocytosis) 
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during internalization of insulin. These interactions suggest that 
RalBP1 is an important actor of endocytosis machinery 
(Nakashima et al., 1999; Jullien-Flores et al., 2000).  
RalBP1 interacts also with Cdk1 and this interaction is 
necessary for phosphorylation of Epsin (clathrin-mediated 
endocytosis protein) by Cdk1 during mitosis in a Ral dependent 
manner. Phosphorylated Epsin is no longer competent for 
endocytosis suggesting that Ral might regulate inhibition of 
endocytosis during mitosis through this mechanism (Rossé et al., 
2003).  
 
1.3.3. PLD1 
Phospholipase D (PLD) hydrolyzes the phosphatidylcholine, 
one of the four major glycerolipids, to phosphatidic acid and free 
choline. Phosphatidic acid is the intracellular lipid mediator of 
many of the biological functions attributed to PLD. In mammals, 
PLD activity regulates the actin cytoskeleton, vesicle trafficking for 
secretion and endocytosis, and receptor signaling (Jenkins and 
Frohman, 2005). 
The activation of PLD1 by phorbol esters, growth factor 
receptor tyrosine kinases and oncogenic tyrosine kinase v-Src is 
dependent on RalA. PLD1 directly binds to the N-terminal region of 
Ral GTPase in a nucleotide-independent manner (Jiang et al., 
1995; Schmidt et al., 1998; Voss et al., 1999). RalA and Arf6 (a 
GTPase implicated in endocytosis and endocytic vesicle recycling) 
cooperate to activate PLD1, a potential functional mechanism to 
link vesicles trafficking and signal transduction (Luo et al., 1998). 
 
1.3.4. ZONAB 
ZONAB (ZO-1-associated nucleic acid-binding protein) is a 
transcription factor of the Y-box family and plays a role in 
regulating epithelial cell proliferation and cell density. At low cell 
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density, a pool of ZONAB is nuclear and represses transcription, 
while at high cell densities, relocation of ZONAB from the nucleus 
relieves transcriptional repression. ZONAB binds to RalA in a GTP-
dependent manner, and this interaction increases with the 
increase of cell densitiy and cell-cell contacts resulting in 
derepression of ZONAB-regulated transcription (Frankel et al., 
2005).  
 
1.3.5. PLC-δ1 
PLC (Phospholipase C) is a family of enzymes responsible for 
hydrolysis of the membrane lipid phosphatidylinositol 
bisphosphate. RalA and RalB bind to PLC-δ1 in a GTP-
independent manner, and promote its activity in vitro and in vivo 
(Sidhu et al., 2005). A more recent study showed that the 
angiotensin II type 1 receptor (AT1R), a G protein-coupled 
receptors important for the blood pressure regulation, activates 
PLC-δ1 through RalA. Activation of AT1R recruits β-arrestin-
RalGDS complex to activate RalA and activation of RalA is 
necessary for PLC-δ1 activation. This mechanism may be 
important for physiological cardiovascular function (Godin et al., 
2010). 
 
1.4. BIOLOGICAL FUNCTIONS  
1.4.1. Cell migration 
A role for Ral in cell migration was first described in 
Drosophila melanogaster: the expression of the dominant-negative 
Ral gene delayed the onset of migration of “border cells” (specific 
follicle cells that migrate in the egg chamber during the fly 
oogenesis), without affecting their migratory speed (Lee et al., 
1996). In mammalian cells, it was shown that dominant-negative 
mutants of Ras and Ral inhibited chemotaxis of mouse myoblast 
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cell line C2C12 in response to bFGF (Basic fibroblast growth 
factor), HGF (Hepatocyte growth factor) and IGF-1 (Insulin-like 
growth factor 1). Expression of an activated mutant of either Ras 
or Ral resulted in increased motility of myoblasts (Suzuki et al., 
2000). 
The individual roles of RalA and RalB in cell migration were 
clarified thanks to the development of the RNAi technology. In 
human bladder and prostate cancer cell lines, depletion of RalB 
resulted in reduction in cell migration. Interestingly, simultaneous 
depletion of both RalA and RalB had no effect on migration, which 
suggests that RalA and RalB might act as antagonists (Oxford et 
al., 2005). 
Our team similarly showed that RalB, but not RalA, is 
required for the cell migration of non-transformed NRK (normal rat 
kidney) cells. Furthermore, the exocyst complex, but not the 
RhoGAP RalBP1, was found to be required downstream of RalB, 
indicating the existence of a RalB/exocyst pathway controlling cell 
migration. It was shown that RalB promotes assembly of exocyst 
complex and mobilization of exocyst to the leading edge of moving 
cells (Rossé et al., 2006).  
The work of other groups indicated that another Ral effector, 
RalBP1, is implicated in the regulation of cell migration. RalBP1 is 
also an effector of R-Ras and is required for adhesion-induced Rac 
activation through Arf6, and for the resulting cell spreading and 
migration of NIH3T3 cells (Goldfinger et al., 2006).  
In human prostate cancer, RalA is important for invasion in 
vivo and metastasis formation (Yin et al., 2007) and RalA 
expression is associated with human tumor progression 
(Varambally et al., 2005). RalBP1 was identified playing a similar 
role as RalA in prostate cancer cells. In fact, depletion of RalA and 
RalBP1 in PC3 human prostate cancer cells inhibited cell 
migration and bone metastasis (Wu et al., 2010). 
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It is still not clear whether RalBP1, which has a GAP domain 
working on Rac and Cdc42 in vitro (Jullien-Flores et al., 1995), 
really acts as a GAP for Rac and Cdc42 during cell motility in vivo. 
 
1.4.2. Apoptosis 
 
RalB/Sec5/TBK1 pathway 
RalB is implicated in survival of tumour-derived cell lines 
(but not of non-transformed cell lines). In fact, tumor cells are 
selectively dependent on RalB expression and not on RalA 
expression, suggesting that RalB GTPase may induce survival 
pathways that are crucial for counteracting oncogene-driven 
apoptotic propensities (Chien and White, 2003). A 
RalB/exocyst/TBK1 pathway has been identified as a mediator of 
the anti-apoptotic activity of RalB in cancer cells. TBK1 (atypical 
IkappaB kinase family member) is a non-conventional activator of 
the NFkB pathway.  RalB promotes Sec5/TBK1 assembly, which 
activates TBK1. This activation inhibits the initiation of apoptotic 
programs (Chien et al., 2006). 
 
RalB/Sec5/JNK pathway 
Various reports are supporting anti-apoptotic roles of Ral 
proteins through the regulation of the JNK pathway. Activation of 
the JNK pathway might have a pro-apoptotic or an anti-apoptotic 
role depending on cell type and stimulus (Lin and Dibling, 2002).  
In Drosophila sensory organs, it was shown that Ral behaves 
as a negative regulator of JNK pathway, and that the exocyst 
complex is required for the execution of Ral apoptotic function. 
Notably, the Ral-JNK signaling is conserved in mammalian cells. 
In fact, to determine which signaling pathways are implicated in 
Ral-dependent apoptotic phenotype, genetic analysis was 
performed in our team. Drosophyla strains with reduced Ral 
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activity were crossed with straines defective in various apoptotic 
pathways, and the resulting apoptotic phenotypes was used as 
functional read out. More specifically, both loss-of-function 
mutations (as well as the expression of the dominant negative 
form) or the ectopic expression of different members of the 
apoptotic pathways were used to either interefere or to activate 
these pathways.    
This Genetic interactions analysis demonstrated that: (i) Ral 
regulates apoptotic programs acting as an upstream negative 
regulator of JNK activity and a positive activator of p38 MAP 
kinase; (ii) the main effector of Ral, the exocyst complex, is 
required for the execution of Ral function in apoptosis; (iii) a 
cascade connecting Ral through the exocyst to HGK/MSN (Ste20 
kinase in mammals and in Drosophila respectevely) was identified 
as the molecular basis of Ral action on JNK; (iv) Ral-dependent 
restriction of JNK activation and the exocyst/HGK relationship are 
conserved in mammalian cells (Balakireva et al., 2006). 
In A14 cells (mouse fibroblasts expressing human insulin 
receptors), expression of an activated version of Rgl2 (with a CAAX 
motif at C-terminal) induced phosphorylation of c-Jun. This 
phosphorylation is abolished by the expression of a dominant-
negative mutant of Ral GTPases (de Ruiter et al., 2000). In a 
mouse model of skin carcinogenesis, RalGDS was necessary for 
Ras induced transformation by providing a survival signal to 
tumor cells. In this model, JNK activation by RalGDS was shown 
to be responsible for the increased survival (González-García et al., 
2005). 
 
1.4.3. Cytokinesis 
Cytokinesis is the last step of cell division that leads to the 
physical separation of the daughter cells. Abscission of the 
intracellular bridge is the last step of this process. 
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In our laboratory, we showed that RalA and RalB have 
distinct roles in two different steps of cytokinesis. RalA is localized 
at the cleavage furrow and is necessary for the stabilization and 
elongation of the intracellular bridge. RalB is localized in the 
intracellular bridge and is necessary for abscission. Depletion of 
RalA or RalB leads to different failures of cytokinesis. Depletion of 
RalA induces accumulation of bi-nucleate cells and depletion RalB 
induces accumulation of bridged cells (Cascone et al., 2008). The 
functions of RalA and RalB in cytokinesis are mediated by their 
exocyst effector (see Chapter 2.3). 
 
1.4.4. Autophagy 
Autophagy is a highly conserved homeostatic pathway by 
which cells degrade damaged proteins and organelles. Portions of 
cytoplasm are sequestered within double-membrane cytosolic 
vesicles (autophagosome) and degraded upon fusion with 
lysosomes. Autophagy might be induced in response to nutrient 
starvations and is essential for cell survival in these conditions.  
It has been shown that RalA functions as an indispensable 
signal mediator for the nutrient-sensing system, by positively 
regulating the mTorc1 complex, which is an inhibitor of autophagy 
(Maehama et al., 2008).  
More recently, it has been shown that RalB, but not RalA, 
and Exo84 are necessary for autophagosome formation and that 
constitutively active RalB (RalB-G23V) is sufficient to activate 
autophagy in human epithelial cells (Bodemann et al., 2011). 
These results suggest that RalB-Exo84 effector complex is a key 
regulator of the cellular response to nutrient deprivation. 
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1.5. RAL IMPLICATION IN CANCER 
The interest in studying the role of Ral proteins in 
oncogenesis started from the discovery that their specific exchange 
factors are effectors of Ras oncoproteins. 
This chapter describes different observations that put Ral 
pathway as a major actor in the transmission of oncogenic signals 
and in the control of metastases formation in human cancer. 
 
1.5.1. Ral in oncogenic transformation. 
Ral itself is not an oncogene, but an actor of oncogenic 
transformation. The historical foci-assay approach with murine 
NHI3T3 cells brought to light the capability of Rals to contribute to 
Ras oncogenic transformation.  
After Raf, RalGDS was identified as a second Ras binding 
protein that can induce oncogenic transformation. More 
specifically, RalGDS was shown to cooperate synergistically with 
mutationally activated Raf to induce foci of growth and 
morphologically transformed NIH 3T3 cells. Moreover, inhibition of 
RalGEFs activity by expression of dominant negative mutant of Ral 
blocks Ras dependent transformation of the fibroblastic cell line 
NIH3T3 (White et al., 1996). Constitutively activated Ral alone 
cannot induce oncogenic transformation, but it enhances the 
transforming activities of both Ras and Raf. Moreover, the 
expression of dominant negative RalA suppressed the transforming 
activities of these two oncogenes (Urano et al., 1996). 
Few years ago, thanks to the development of human 
cancerogenesis models (Hahn et al., 1999), important 
dissimilarities between human and mouse transformation 
processes were shown, suggesting that the underlying 
mechanisms are not identical (Hamad et al., 2002; Rangarajan et 
al., 2004). Many studies in murine models had supported a model 
in which Raf serine/threonin kinase (c-Raf1, A-Raf et B-Raf) are 
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the major actors of the transmission of oncogenic properties of Ras 
proteins.  On the contrary, in human cells, RalGEF, and not the 
Raf or PI3-kinase pathway, is sufficient to mediate Ras 
transformation (Hamad et al., 2002).  
In several human cell lines (fibroblasts, astrocytes and 
embryonic kidney cells (HEK)), oncogenic capacities of Ras seem to 
be recapitulated by Ral activation through: expression of ectopic 
mutant Ras (Ras mutant that activates specifically Ral pathway) or 
by the constitutive activation of Rlf (Rlf-CAAX), the exchange factor 
of Ral (Hamad et al., 2002). 
Cell type specific differences about pathways required in 
transformation were discovered (Rangarajan et al., 2004). 
Immortalized human fibroblasts need activation of Raf and 
RalGEFs, immortalized human embryonic kidney cells (HEK-HT) 
need activation of PI3K and RalGEFs, and epithelial mammary 
cells need activation of the three pathways. In this work, the 
important result regarding Ral is that RalGEF/Ral pathway is 
always required (figure I4). 
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Figure I4: Pivotal contribution of Ral activation to 
oncogenic Ras-induced tumorigenicity. A variety of primary 
human cell types isolated from normal tissue can acquire 
tumorigenic phenotypes upon forced expression of telomerase 
together with SV40 large and small T-antigen and oncogenic 
Ras (ras12V). Substitution of ras12V with effector mutations 
that discriminate between three families of Ras targets – Raf 
(ras12V,35S), RalGDS (ras12V,37G) and phosphoinositide 3-
kinase (PI3K) (ras12V,40C) – reveals selective requirements for 
activation of these pathways to drive tumorigenic 
transformation of breast epithelia, fibroblasts and kidney 
epithelia. While these three cell types display dissimilar 
sensitivity to Ras-induced activation of Raf family and PI3K 
family proteins (as indicated by the arrows), activation of Ral 
GTPases is apparently a common prerequisite to development of 
tumors in nude mice (Camonis et al. 2005). 
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Downstream Ral,  a role  for exocyst subunits Sec5 and 
Exo84 has been reported in RalGEF-mediated transformation of 
HEK-HT cells, in oncogenic Ras-mediated tumorigenesis of human 
cells and in the proliferation of Ras-transformed human cells, 
suggesting that Rals promote oncogenic Ras-mediated 
tumorigenesis through, at least in part, its exocyst effector (Issaq 
et al., 2010). 
Activation of RalA seems to be a critical step in 
tumorigenesis of human cells. RalA is activated in a large panel of 
cell lines derived from human pancreatic tumors. About 90% of 
pancreatic cancer has Ras mutation. Chronic depletion of RalA in 
these cell lines inhibits the ability of cells to form tumors after 
subcutaneous injection in nude mice (Lim et al., 2006). 
Additional evidence about implication of Ral in oncogenesis 
comes from the discovery made by Sablina (Sablina et al., 2007) 
that RalA is a target of phosphatase 2A (PP2A). Biallelic mutations 
of the subunit Ab of PP2A are frequently found in many human 
tumors. RalA is phosphorylated on serine 183 and 194, potentially 
by Aurora A kinase. These phosphorylation sites are PP2A 
substrates, and are associated to a 5 times increase of active RalA 
pool. Disphosphorylation of RalA by PP2A is a major mechanism of 
cell proliferation restriction by PP2A. These results suggest that 
PP2A subunit Ab acts as tumor suppressor by regulating RalA 
function. 
 
1.5.2. Ral controls the proliferation/survival balance of 
human cancer cells 
Discrete interlocking contribution of Ral GTPases to 
proliferation and survival of cancer cells was described in cell lines 
derived from human tumors using loss of function analysis (Chien 
and White, 2003). In this work, RalB was found to be essential for 
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the survival of variety of tumor cells, but not of normal epithelial 
cell lines. On the other side RalA was not essential for the survival 
or proliferation of adherent culture cells, but it was required for 
proliferation of anchorage-independent cancer cells. 
A functional interaction between RalA and RalB is supported 
by the observation that depletion of RalA inhibits the sensitivity of 
tumor cells to RalB depletion (Camonis and White, 2005).  In other 
words, cancer cells need RalB expression and cannot survive 
without it, pointing to the notion that RalB renders cancer cell 
addicted. RalA depletion abrogated cancer cell addition to RalB, 
suggesting RalA and RalB activities must be in equilibrium in 
cancer cells.  
The fact that RalA or RalB depletion causes diverse 
phenotype in normal and cancer cells indicates that the two Rals 
may collaborate in the maintenance of oncogenic transformation 
by controlling survival and proliferation signals. Proliferative 
pressure dependent on RalA should be counterbalanced by 
inhibition of apoptosis dependent on RalB (Figure I5). The 
mechanistic basis of this divergence of RalA and RalB functions 
remains still to be clarified. One likely possibility rests in a 
different cell compartmentalization of the two Ral proteins. 
Alternatively, RalA and RalB may have different affinities for their 
effectors, due to the small difference in aminoacids around the 
effector domain.  
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Figure I5: The RalA–RalB balancing act in tumor cells. 
Under conditions of oncogene-induced stress, the increased 
apoptotic propensity driven by RalA is offset by RalB-dependent 
survival signals (a). Inhibition of RalB function under these 
conditions therefore leads to apoptosis (b). Reducing 
proliferative pressure by inhibition of RalA restores balance to 
the system, relieving dependency on RalB survival signals (c). 
This relationship, suggests that RalB-dependent survival 
pathways represent conceptually ideal targets for anticancer 
drugs with high tumor-cell-specific potency (Camonis and White, 
2005).  
 
1.5.3. Ral in metastasis formation. 
Cancer cells spread by infiltrating adjacent tissues (invasion) 
and subsequently traveling to distant organs through the blood or 
lymph vessels (metastasis). Metastatic progression is a multistep 
process. Tumor cells, particularly those of epithelial origin, 
frequently loose in their initial stages cadherin-based cell–cell 
adhesion, become able to degrade the basement membrane and 
acquire a motile phenotype. Remodeling of the actin cytoskeleton 
plays a crucial role in all these steps. 
Several works supported the notion that RalGEF-Ral 
signaling is implicated in tumor invasion.   
For example, 3T3 cells transformed by mutant RasV12G37, a 
Ras effector mutant that activates RalGEF but not Raf or PI3 
kinase, form aggressive metastasis, indicating that the signaling 
pathway mediated by RalGEFs facilitates, in combination with 
ERK pathways, the acquisition of an invasive phenotype (Ward et 
al., 2001). Consistently, RalB dominant negative inhibits 
metastatic activity of RasV12G37.  
In in vivo experimental metastasis assay, using chinese 
hamster cells (Tchevkina et al., 2005), Ha-Ras was shown to 
stimulate mestatasis formation via Ras-RalGDS-RalA pathway. 
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RalA alone is able to increase the mestatatic activity of fibroblasts 
spontaneously transformed or transformed by Rous sarcoma 
virus. Moreover, during in vivo selection, cells acquire a high 
metastatic potential after activation of endogenous RalA.  
Chronic RalA depletion inhibits the formation of bone 
mestastasis by human prostate cancer (DU145 cells). Consistently, 
activation of Ral pathway is necessary and sufficient for bone 
mestastasis formation by DU145 cells. The requirement of Ral A 
for bone metastasis is probably cell specific: in fact, RalA depletion 
or RalB depletion in mammary cancer cells (MDA-MB-231), or in 
colorectal cancer cells (HT29), does not inhibit bone metastasis 
formation (Yin et al., 2007) 
 
1.5.4. Mutations and abnormal expression of Ral 
pathway components are found in human cancers 
 The previous paragraphs summarized the accumulating 
evidence that the Ral pathway is implicated in oncogenesis using 
in vitro cell lines or mouse in vivo models. This notion was 
corroborated and strengthened by the discovery of mutations of 
the components of the Ral pathway in human tumors. For 
example, mutations of Rgl1 and exocyst subunit Sec6 were 
reported in breast cancer. Similarly, RalGDS and exocyst subunit 
Sec8 where found in colon cancer (Sjoblom et al., 2006). Notably, 
missense RalA mutation was found to occur in one of a panel of 
bladder carcinoma cell line (UM-UC-6 cell line). 
Deregulation of Ral pathway components was reported at 
expression level. RalA was discovered to be overexpressed in 
metastatic prostate cancer (Varambally et al., 2005). RalA mRNA 
was found also significantly overexpressed in human bladder 
cancer. Moreover, RalA overexpression is further associated with 
invasion. RalB was shown to be reduced in hepatocellular 
carcinoma, seminoma, ovarian carcinoma, and meningioma (Smith 
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et al., 2007). It was also shown that RLIP is overexpressed in lung 
and ovary cancer (Awasthi et al., 2008).  
The discovery that Ral regulators and effectors are 
deregulated in human cancer reinforce to the notion that Ral 
maybe a major axis of oncogenic signaling downstream of Ras. 
 
2. EXOCYST 
 
2.1. DISCOVERY 
Exocyst is an eight subunit complex: EXOC1/Sec3, 
EXOC2/Sec5, EXOC3/Sec6, EXOC4/Sec8, EXOC5/Sec10, 
EXOC6/Sec15, EXOC7/Exo70 and EXOC8/Exo84 (human/yeast 
nomenclature). Mutations of these subunits were identified in 
yeast in a screening for secretion mutants (Novick et al., 1980). 
Analysis of this complex, in particular in yeast, consolidates its 
role in polarized secretion (TerBush and Novick, 1995): In yeast, 
exocyst contributes to post-Golgian vesicle targetting to the 
plasmamembrane via an interaction with Rab GTPase Sec4p (Guo 
et al., 1999). This complex is highly conserved in yeast, Drosophila 
and human (Hsu et al., 1996).  
Even though the exocyst complex mediates many of the Ral 
cellular functions and it is considered the major RalA/B effector, 
the functional relevance of the Ral binding to Exocyst is still not 
fully understood. A tentative working model has been proposed in 
which Sec5 and Exo84 belong to two different sub-complexes of 
exocyst and Ral proteins assemble the complex by interacting with 
both (Camonis and White, 2005) (Figure I3).  
Crystallography of exocyst subunits, Sec3 (Baek et al., 2010; 
Yamashita et al., 2010), Sec5 (Fukai et al., 2003), Sec6 (Sivaram et 
al., 2006), Sec15 (Wu et al., 2005), Exo84 (Jin et al.,2005; Dong et 
al., 2005) and Exo70 (Dong et al., 2005; Hamburger et al., 2006; 
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Moore et al., 2007). In spite of low sequence homology (less than 
10%) between esocyst subunits Sec6, Sec15 and Exo84 and 
Exo70, crystallography shows that they share the same novel fold, 
made of compact helical-bundle repeats connected by flexible 
linkers (Croteau et al., 2009). 
 
 
Figure I5A: The exocyst subunits share the same helical bundle 
structures. The known structures of the exocyst subunits are shown: 
Exo70, Exo84, Sec15 and Sec6.  
 
2.2. BIOLOGICAL FUNCTIONS 
 
The exocyst complex has been shown to be required for 
several biological processes involving membrane plasticity. 
 
2.2.1. Vesicle trafficking 
The role of exocyst in exocytosis was historically studied in 
yeast. During exocytosis vesicles are formed from a donor 
compartment, translocated to the plasmamembrane, where 
tethering, docking and fusion take place. This phenomenon 
requires SNARE (SNAP Receptor) proteins. Pairing of SNARE on 
vesicle (v-SNAREs) with target membrane SNAREs (t-SNAREs) is 
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crucial (Brown and Pfeffer, 2010). Exocyst was found to be highly 
concentrated at regions were vesicle fusion was very active; it was 
proposed that the exocyst directs vesicles or restricts their fusion 
(TerBush and Novick, 1995). Moreover, always in yeast, the 
exocyst complex was implicated in the delivery of post-Golgi 
vesicles to the plasma membrane (Terbush et al. 1996). In 
epithelial cell line MDCK, exocyst is required to specify the delivery 
of vesicles containing membrane proteins to sites of cell-cell 
contact (Grindstaff et al., 1998; Lipschutz et al., 2000).  
The exocyst collaborates with SNARE in vesicle tethering. It 
was shown that the subunit Sec6 of the exocyst binds to t-SNARE 
at the plasma membrane (Sivaram et al. 2005). The exocyst keeps 
the vesicle bound to the plasmamembrane until the SNARE-
dependent fusion machinery acts (Munson M, Novick P. 2006). It 
was proposed that the exocyst as a dynamic complex (Terbush et 
al. 1996) can have many binding partners, and integrate a large 
number of signals helping in determining the proper conditions to 
facilitate SNARE pairing (Brown and Pfeffer, 2010).  
 
2.2.2. Polarization of epithelial cells  
Exocyst is an important regulator of epithelial polarity in 
Drosophila Melanogaster, but the mechanisms of its action is still 
partially known. A model was proposed (Langevin et al., 2005), 
whereby the physical interaction between Armadillo/beta-catenin 
and Sec10 allows the exocyst to regulate Drosophila Epithelial 
Cadherin (DE-cadherin) trafficking. New pieces of evidence show 
that epithelial polarity in the Drosophila embryo requires the 
exocyst complex subunit homolog Exo84. Exo84 regulates Crumbs 
localization, a key determinant of epithelial apical identity 
(Blankenship et al., 2007). 
After establishment of E-cadherin-dependent cell-cell 
contacts, Sec6 and Sec8 subunits are recruited to the lateral 
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membrane (Grindstaff et al., 1998; Yeaman et al., 2004). So, it was 
proposed that the exocyst promotes the formation of basolateral 
domain of epithelial cells by directing Golgi-derived vesicles to cell-
cell contact sites.  
It remains not clear whether the exocyst contribution to 
epithelial polarity is, at least in part, due to its role in polarized 
secretion, by mediating exocytosis from Golgi or by regulating 
endosome recycling. 
 
2.2.3. Neuronal development  
Exocyst components, because of their function in polarized 
secretion, have been involved in different aspects of neuronal 
development, which consists in a succession of events ending with 
synapse formation.  
For examples, the exocyst was shown to be implicated in 
synaptogenesis: it specifies sites for targeting vesicles at domains 
of neurite outgrowth and potential active zones (Hazuka et al., 
1999). During Drosophila development, photoreceptor cells (PRCs) 
with reduced Sec6 show transport failure and accumulation of 
secretory vesicles (Beronja et al., 2005). Sec5 and Sec6 subunits 
play an important role in neurite growth, synaptic transmission 
and oocyte polarization (Murthy et al., 2003, Murthy et al., 2005; 
Murthy and Schwarz, 2004).  
Ral GTPases are mediators of neurite branching. The two Ral 
proteins, RalA and RalB, promote branching through distinct 
pathways, involving the exocyst complex and phospholipase D, 
respectively (Lalli and Hall, 2005). Neuron cells depleted of the 
exocyst subunits Sec6, Sec8 or Exo84, lost their polarity; 
consistently, the exocyst was found to interact locally with the PAR 
polarity complex. Moreover, at early stages of neuronal 
polarization, RalA local activation regulates spatially the exocyst 
and favours exocyst assembly in nascent axon (Lalli, 2009).  
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2.2.4. Cell migration 
It is hard to dissociate between exocyst function in exocytosis 
and exocyst function in cell migration. A series of very convincing 
observations supporting this concept were obtained thanks to live 
TIRF microscopy: exocytic vesicles were preferentially distributed 
close to the leading edge of motile astrocytes cells, the exocytic 
process was found to be organized into hotspots, and the polarized 
delivery of vesicles and their clustering in hotspots was dependent 
on the intact exocyst complex. Clearly, the exocyst plays a role in 
vesicle delivering to the leading edge and in determining the 
tethering sites during polarized cell motility (Letinic et al, 2009). 
In our group, it was shown that depletion of various exocyst 
subunits impairs the motility of NRK cells by using both wound-
healing and Boyden chamber motility assays. The exocyst requires 
RalB to localize at the leading edge and to fully assemble (Rossé et 
al. 2006).  
 
2.2.5. Cytokinesis   
The role of the exocyst complex in cytokinesis was first 
identified in Yeast. It was shown that the exocyst complex is 
required for the formation of the cleavage site and cell separation 
(Wang et al., 2002; Dobbelaere and Barral, 2004). Ingression of the 
cleavage furrow requires addition of new membrane by vesicle 
transport and fusion, and the loss of exocyst abolishes the 
completion of furrow ingression (VerPlank and Li, 2005). In 
mammalian cells, it was shown that the exocyst is localized at the 
intracellular bridge and its disruption inhibits abscission (Gromley 
et al., 2005). 
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3. WAVE REGULATORY COMPLEX (WRC) 
Cell motility depends on the assembly of actin filaments at 
their leading edge to generate force that pushes the plasma 
membrane and propels cells forward. This process is tightly 
regulated in space and time so that the assembly of a branched 
network of actin filaments is restricted beneath the advancing 
plasmamembrane. As these filaments grow, they push the 
membrane forward. 
 
3.1. NUCLEATING ACTIN  
Cells use two major mechanisms to nucleate new actin 
filaments: a mechanism is mediated by the Arp2/3 complex and 
another one is mediated by Formins. Arp2/3 and Formins act in 
different ways.  
Arp2/3 complex produces branched actin filament starting 
on a preexisting actin network. The free end of the new filament 
elongates until a capping protein terminates growth. The branched 
network that is generated as consequence of Arp2/3 activation is 
capable of generating protrusive forces that propels lamellipodia 
protrusion, adhesion, phagocytosis, endocytosis, vescicle and 
organelle motility trafficking within and from Golgi apparatus and 
exocytosis (Goley and Welch, 2006).  
Formins produce unbranched filaments for actin bundles 
found in filopodia and the cytokinetic contractile ring (Wallar and 
Alberts, 2003). Formin remains associated with the growing end of 
the filament, providing an anchor and protection against capping. 
 
3.2. THE Arp2/3 COMPLEX  
The Arp2/3 complex is a stable assembly of seven proteins: 
Arp2, Arp3, and the subunits p40/ARPC1, p34/ARPC2, 
p21/ARPC3, p20/ARPC4 and p16/ARPC5 (Machesky et al., 1994; 
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Mullins et al., 1998) (Figure I6). Arp2 and Arp3 belong to the 
family of actin-related proteins (Arps) and are predicted to share 
the same protein fold as actin, although the amino acid sequence 
is divergent from that of conventional actins (Kelleher et al., 1995). 
Two models have been proposed to explain how the activated 
Arp2/3 complex interacts with a filament to initiate branching: the 
first one favours the possibility that the Arp2/3 complex branches 
by binding to the side of pre-existing filaments (Amann and 
Pollard, 2001; Higgs and Pollard, 1999); the second, instead, 
proposes that branching can occur only at the barbed ends of 
growing filaments (Boujemaa-Paterski et al., 2001; Pantaloni et al., 
2000; Pantaloni et al., 2001). Whatever the case, a consensus has 
been reached that the Arp2/3 complex generates a branched array 
of actin filaments.  
At the side of a pre-existing filament (mother filament), the 
Arp2/3 complex can nucleate a new filament (daughter filaments) 
at an angle of 70°, thus generating y-branched actin network 
(Machesky et al., 1994; Mullins et al., 1998) (Figure I6).  This 
property accounts for the central role of the Arp2/3 complex in the 
formation of highly branched actin filament structures at the 
leading edge of lamellipodia in motile eukaryotic cells (Svitkina and 
Borisy, 1999).  
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Figure I6: Schematic representations of the precursors and 
assembled components of the branch junction. (A) Inactive 
Arp2/3 complex and a standard actin filament. (B) Model of the 
branch junction (Rouiller et al. 2008). 
 
 
Actin remodelling in the lamellipodium is also coupled to the 
formation of adhesive contacts that link the actin cytoskeleton to 
the extracellular matrix. Emerging evidences indicate that the 
Arp2/3 complex might be recruited to sites of nascent focal 
contacts through a direct interaction with the linker region of 
vinculin, a protein associated to the cytosolic domain of integrin 
receptor (DeMali et al., 2002). Similarly, direct linkages between 
the actin polymerization machinery and adhesion molecules have 
also been reported in the context of cell-cell adhesion. Recently, it 
has been observed that E-cadherin interacts with the Arp2/3 
complex to promote local actin assembly and lamellipodial 
protrusion during the formation of early cell–cell adhesive contacts 
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(Kovacs et al., 2002). Alpha-Catenin can compete for actin 
filaments, and thus it can abolish the activity of Arp2/3. This 
suggests the following model: at adherent junctions, beta-catenin 
form clusters and recruits alpha-catenin that can inhibit the 
Arp2/3 complex, and so inhibits lamellipodia formation, in order 
to form stable contact point (Pokutta et al., 2008). 
Very interestingly, the Arp2/3 compelx interacts with the 
exocyst complex, in particular with the Exo70 subunit. Exo70 was 
shown to regulate actin polymerization at the leading edges of 
migrating cells, via direct control of Arp2/3 activation (Zuo et al., 
2006). 
Notably, the Arp2/3 complex is autoinhibited. In order to be 
activated it requires the engagament with Nucleation Promoting 
Factor (NPF) proteins. Members of the WASP (Wiskott-Aldrich 
Syndrome Protein) and WAVE (WASP family Verprolin-
homologous) families of proteins are the major NPFs proteins for 
the Arp2/3 complex.  The NPF binds directly the Arp2/3 and 
delivers an actin monomer that forms with Arp2/3 a starting 
nucleus for new filament (Figure I6). 
 
Structural basis of actin branching is now highly debated 
because of the dendritic nucleation model challenging.  
Electron tomography revealed the three dimensional 
organization of lamellipodia and showed that in lamellipodia from 
four cell types, actin filaments are almost exclusively unbranched. 
Majority of apparent filament junctions proved to be overlapping 
filaments, rather than branched end-to-side junctions (Urban et 
al. 2010, Small, 2010). However, there are several important 
shared points about Arp2/3 and WRC. Arp2/3 is a major actin 
nucleation factor at the leading edge, it is highly enriched at the 
leading edge and is an effector of WRC, which localizes at the 
leading edge (Higgs, 2011). Two electron electron microscopy 
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techniques probably counterbalance their potential artefacts about 
existence of branched actin filaments in lamellipodia (Yang et al. 
2011). The size on the studied region, their density and the length 
of the observed filaments make orbservable branches rare (Insall, 
2011) (Figure I7A). 
 
 
Figure I7A: Two models of leading edge actin network 
architecture. Left: dendritic branch model. WRC activates 
Arp2/3 complex. Arp2/3 complex is also activated by binding to the 
side of an actin filament close to the plasmamembrane. This 
coactivation by WRC and filament side binding results in branch 
formation, with Arp2/3 complex forming the link between the pointed 
end of the new filament and the side of the activating filament. Right: 
crosslinked network model. WRC activates Arp2/3 complex but it 
does not bind to the side of an existing filament, so that branches do 
not assemble (Higgs, 2011). 
 
 
3.3. WASP AND WRC ACTIVATE Arp2/3  
A large family of NPFs were identified through the presence 
of a characteristic C-terminal VCA domain (Verprolin homology, 
Cofilin homology, and Acidic region). This family is subdivided into 
four NPF subfamilies based on their N-terminal domains: WASP, 
WAVE and more recently WASH, WHAMM (Linardopoulou et al., 
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2007; Campellone et al., 2008; Zuchero et al., 2009) and JMY 
(Rottner et al., 2010). The WASP (Wiskott-Aldrich Syndrome 
Protein) and WAVE (WASP family Verprolin-homologous) are the 
most studied, they activate Arp2/3 complex in responses to 
signaling events downstream of the Rho-family GTPases Cdc42 
and Rac.  
WASP protein was identified as the causative gene of 
Wiskott-Aldrich Syndrome, a rare, X-linked disease characterized 
by immunodeficiency, thrombocytopenia and eczema (Derry et al., 
1994). Expression of WASP is restricted to hematopoietic cells, 
hence the restricted defects in the syndrome. The other member of 
WASP group in mammals, neural WASP (N-WASP), originally 
identified in brain tissues, is more widely expressed than WASP 
(Miki et al., 1996). 
WAVE1 protein was isolated in a database search for 
WASP-like proteins (Machesky et al., 1998) and subsequently two 
other members of WAVE family, WAVE2 and WAVE3, have been 
identified (Suetsugu et al., 1999). In mammals, WAVE2 is 
ubiquitously expressed while WAVE1 and WAVE3 are particularly 
enriched in brain.  
The VCA region is the minimal essential region for the 
activation of the Arp2/3 complex by WASP and WAVE proteins 
(Machesky et al., 1999; Rohatgi et al., 1999; Yarar et al., 1999). 
Within the VCA domain, the V region binds G-actin monomers 
(Miki et al., 1998a), the A region directly binds the Arp2/3 complex 
(Machesky and Insall, 1998) and the C region drives the 
conformational changes in the Arp2/3 complex necessary for its 
activation (Panchal et al., 2003). Branch formation requires the 
cooperation of VCA, Arp2/3 complex, the first actin monomer, and 
the mother filament. Concomitant binding of the VCA region to the 
Arp2/3 complex and actin monomer leads to the formation of a 
complex that serves as protonucleus for the further addition of 
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monomer, thus promoting filament elongation (Pollard and Borisy, 
2003; Takenawa and Miki, 2001).  
The N-terminal parts of WASP and WAVE proteins are 
significantly divergent. WASP proteins display a common modular 
organization, which includes a WASP-homology1 domain (WH1), 
also called Ena/VASP homology 1 (EVH1) domain, a basic region 
(B) and a GBD (GTPase Binding Domain) domain, positioned next 
to a proline-rich region (Figure I7). WH1/EVH1 domain of WASP 
and N-WASP tightly binds to a specific proline-reach sequence of 
the WASP-interacting protein (WIP) (Volkman et al., 2002), a 
member of a family of regulators of WASP-mediated actin 
polymerization (Ramesh et al., 1997) that includes WIP- and 
CR16-homologousprotein (WICH) and CR16 (Kato et al., 2002; 
Zettl and Way, 2002). The GBD and B regions associates with 
GTP-loaded Cdc42 and PtdIns(4,5)P2, respectively, while a 
plethora of Src-homology (SH)3-containing proteins (Rohatgi et al., 
2000; Takenawa and Miki, 2001) associate with the polyproline 
motifs in the proline-rich region. Moreover, the B and the proline-
rich regions have also been implicated in F-actin (Suetsugu et al., 
2001) and profilin (Suetsugu et al., 1998; Yang et al., 2000; Yarar 
et al., 2002) binding, respectively. 
The N-terminal region of WAVE proteins contains a WAVE 
(also known SCAR)-homology domain (WHD/SHD) and a basic 
region. The basic region is responsible for the binding with PtdIns 
(3,4,5)P3 that is important for WAVE2 localization (Oikawa et al., 
2004). In contrast to WASP and N-WASP, WAVE proteins do not 
contain GBD motifs, lacking in this way of a surface directly 
associating Rho GTPases. Alternatively, WAVEs contain a proline-
rich region that mediates the association with insulin receptor 
substrate IRSp53, which has been implicated in physically linking 
WAVE2 and Rac (Miki et al., 2000) (Figure I7).  
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Figure I7: Domain organization of WASP/Scar proteins. EVH1, 
Ena/Vasp homology 1 domain; B, basic region; GBD, GTPase-binding 
domain; Poly Pro, proline-rich region; SHD, Scar homology domain; 
WH2, verprolin-like or WASP homology 2 domain; C, central or 
connecting domain; A, acidic domain (Kelly et al. 2006). 
 
 
3.4. THE WAVE REGULATORY COMPLEX (WRC) 
The WHD/SHD domain of all three WAVE proteins 
contributes to the formation of a multimeric-complex, first 
identified for WAVE1 (Eden et al., 2002) and later also for WAVE2 
(Innocenti et al., 2004) and WAVE3 (Stovold et al., 2005). This 
pentameric heterocomplex consists of WAVE, Abi (Abelson-
interacting protein), Nap1 (Nck-associated protein 1), Cyfip 
(p140/Pir121/Sra1) and Brick (HSPC300) proteins (Eden et al., 
2002; Gautreau et al., 2004; Innocenti et al., 2004). Nterminus of 
Cyfip was shown to interact specifically with Rac-GTP, which is a 
major activator of WRC (Kobayashi et al., 1998).  
 We now know that RhoGTPase Rac1 stimulates actin 
branching at lamellipodia by relaying signals to WRC that activates 
Arp2/3-mediated actin polymerization. Historically, it was the 
Takenawa group that proposed the critical role of Wave 
downstream of Rac in actin cytoskeleton remodeling required for 
membrane ruffling. Dominant-active Rac mutant induces the 
translocation of endogenous WAVE to membrane ruffling regions 
(Miki et al., 1998a). 
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The WHD domain of WAVEs interacts with Abi1/2 and Brick 
members of the complex (Gautreau et al., 2004). Cyfip and Nap1 
interact with WAVE2 and Abi1. Consistently, various WRC 
subunits was shown to translocate to the protrusion tips after 
microinjection of constitutively active Rac (Steffen et al., 2004). A 
series a co-precipitation and gel filtration experiments pointed out 
the fact that the five subunits of WRC are constitutively and 
strongly associated.  The integrity of the complex is essential for 
the stability of all its members and for the proper localization of 
the complex.   
The WRC complex composition is conserved, as well as its 
integrity and its function. For example, in adherent Drosophila cell 
line, Abi, Cyfip and Kette (Nap1) protect Scar (Wave) from 
proteasome-mediated degradation and are critical for Scar 
localization and for the generation of Arp2/3-dependent 
protrusions (Kunda et al., 2003).  
WRC expressed by HeLa cells is composed of Wave2, Abi, 
Cyfip, Nap1, and Brick. In other cell lines or tissues, WRC may be 
composed of homologous subunits (WAVE1, WAVE2, WAVE3; 
Abi1, Abi2) encoded by paralogous genes or by isoforms derived 
from alternative splicing (for example Abi1 has 10 isoforms) 
(Gautreau et al., 2004; Innocenti et al., 2004). 
 
3.5. WRC ACTIVATION MECHANISM 
While the mechanism of activation of WASP proteins has 
been largely clarified, the mode through which WAVE proteins are 
regulated was highly debated and many questions still remain 
unanswered. However, in both cases, activation occurs via un-
masking of the VCA motif which is sequestered by intra-molecular 
or intra-complex interactions in the basal inactive state. 
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3.5.1. The case of Wasp 
Isolated, full length WASP and N-WASP are autoinhibited 
due to conformational constrains. The VCA region is masked 
through the binding of the GBD domain to the C region. This 
conformation prevents the association of WASP with the Arp2/3 
complex (Miki et al., 1998b). The release of autoinhibition and 
activation of WASP proteins is promoted by proteins or molecules 
that interact with the N-terminal region of WASP / N-WASP and 
cause a conformational changes leading to the exposure of the 
VCA domain (Figure I8). Activated Cdc42 can, for instance, bind to 
the GBD domain, while phosphatidylinositol-4,5-diphosphate 
(PIP2) binds a small region of basic residues (B region) close to the 
GBD domain. Binding of Cdc42 to WASP/N-WASP, is sufficient to 
activate the protein. Addition of PIP2 increases this activity, in a 
synergic way. WIP is a protein family (WIP, CR16, and WICH) that 
bind directly to WASP or N-WASP and cooperate with WASP/N-
WASP to form filopodia in fibroblasts (Vetterkind et al., 2002). 
Additional modulatory roles are also exerted by a plethora of SH3-
containing proteins that bind to the proline rich region of 
WASP/N-WASP and stimulate these NPFs, often acting in a 
cooperative manner with Cdc42 and PIP2 (Kim et al., 2000; 
Rohatgi et al., 2000; Takenawa and Miki, 2001). These latter 
features support to the notion that WASP/N-WASP are the 
“convergent nodes or coincident detectors” of different signalling 
inputs leading to de novo actin polymerization. 
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Figure I8: Architecture of N-WASP and WRC at resting state. 
The N-WASP complex is dimeric. The WCA domain is intramolecularly 
masked in N-WASP, but WIP is required for a tightly inhibited state. 
WIP provides an additional WH2 domain indicated by ‘W’. The WAVE 
complex is pentameric. This complex is also inhibited, but the WCA 
domain of WAVE is masked by an intermolecular interaction within 
the complex, most likely with Sra and/or Nap. The linker regions 
between N-terminal domains and WCA domains of N-WASP and 
WAVE are rich in prolines, and thus display binding sites for 
numerous proteins containing SH3 domains. The Abi subunit of the 
WAVE complex also contains an SH3 domain that has been reported 
to bind to several proteins. It is not known, however, whether this 
SH3 domain is free to interact at resting state or masked by an 
interaction with proline-rich linker regions of WAVE or Abi (Derivery 
and Gautreau, 2010). 
 
 3.5.2. Multiple signal activation model of WRC 
Several events have been proposed to stimulate somehow 
WRC activity (Rac binding, PIP3 interaction, phosphorylations). 
However none of these events alone is sufficient for a substantial 
stimulation of Arp2/3-dependent in vitro actin polymerization. 
Indeed, it was recently shown that activation of the WRC complex 
requires simultaneous interactions with prenylated (membrane 
targeted) Rac-GTP and acidic phospholipids (including PIP3), 
together with a specific state of phosphorylation. Together these 
signals promote full activation in a highly cooperative process on 
the membrane surface, by inducing an allosteric change in the 
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complex rather than by simple recruitment or by dissociation of 
the subunits. (Lebensohn and Kirschner, 2009) (Figure I9). Thus, 
WRC, similarly to WASP, acts as coincident detectors of multiple 
and converging signaling pathways that controls not only its 
activity, but also its spatial localization.  
 
 
 
 
 
Figure I9: Regulation of SCAR/WAVE proteins. Model for WAVE2 
Function Counterclockwise from top right, the WAVE2 complex is 
intrinsically inactive. Phosphorylated WRC can bind acidic 
phospholipids, including PIP3, or prenylated Rac-GTP, but binding to 
either is not sufficient for activation. Binding to both acidic 
phospholipids (PIP3) and prenylated Rac-GTP activates the WRC. 
Cooperative association of multiple complexes on the membrane 
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results in greatly enhanced actin nucleation. (Lebensohn and 
Kirschner, 2009). 
 
Recently, the crystalization of the Wave complex gave more 
conformational data to understand the complex activation. 
Structural and biochemical studies have shown that VCA motif is 
sequestered by a combination of intra-molecular and inter-
molecular contacts within the Wave complex. Phospholipid 
signaling, Rac and kinases are all required to unlock the inhibited 
conformation that masks the VCA domain, enabling the latter to 
associate and activate the Arp2/3 complex (Chen et al., 2010).  
 
 
 
 
 
Figure I10: Structure and regulation of the WRC. (A) Structure of 
the WRC. Sra1 (green), Nap1 (blue), HSPC300 (yellow), WAVE1 
(magenta) and Abi2 (orange). (B) Schematic showing the proposed 
Wave complex activation mechanism. Unstimulated WRC sequesters 
the VCA domain of WAVE1, rendering it inactive. Upon binding of the 
Sra1 subunit to activated Rac1, the entire complex is recruited to the 
plasma membrane and the VCA domain is released from 
sequestration. The interaction between the positively charged face of 
the WRC and negatively charged phospholipids in the plasma 
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membrane ensures the VCA domain is oriented in the right way to 
interact with the actin-polymerizing machinery in the cytoplasm 
(Davidson and Insall, 2010 ; Chen et al. 2010). 
 
This set of observations highlights the fact that the 
mechanisms of regulation of this critical machinery are far from 
being fully comprehended. It is likely that additional modulatory 
factors, by transiently associating with WRC components, 
contribute to the switch to a fully active unit. These factors are 
predicted to be critical to transduce signalling from a variety of 
cues that must control, in a spatially restricted and temporally 
defined manner, when and how WAVE becomes active. 
 
 
3.6. BIOLOGICAL FUNCTIONS OF WASP AND WRC  
WASP and WAVE family of proteins are involved in several 
biological functions that are accompanied by the activation of 
Arp2/3 complex.  
WASP proteins have been reported to be involved in a variety 
of biological processes: adhesion, phagocytosis, endocytosis, 
vescicle and organelle motility trafficking within and from Golgi 
apparatus and exocytosis (Goley and Welch, 2006). WASP family 
proteins have central roles in membrane trafficking, and are 
manipulated during infection by intracellular pathogens. Recently, 
an emerging role for WASPs was found in cytokinesis (Pollitt and 
Insall, 2008). 
WAVE family proteins are the NPFs responsible for 
activating the Arp2/3 complex in lamellipodia during cell 
migration and in the formation of macropinocytic structures. 
Consistent with this function, in mammalian cells all three WAVE 
isoforms localize to the leading edge of migrating cells (Miki et al., 
1998b; Nozumi et al., 2003; Stovold et al. 2005). Analysis of 
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different cell lines in which the WAVE activities were perturbed by 
mutations or RNAi, revealed that WAVE2 (Yamazaki et al., 2003; 
Yan et al., 2003) and WAVE3 (Sossey-Alaoui et al., 2005) are 
crucial for lamellipodia formation and directed cell migration, 
whereas WAVE1 is important for formation of dorsal ruffles, which 
are specialized migratory and endocytic structures detected on the 
apical surface of mesenchymal and epithelial cells (Buccione et al., 
2004), and for stabilization of lamellipodial protrusions (Suetsugu 
et al., 2003; Yamazaki et al., 2005). 
 
 
4. SH3BP1 
SH3BP1 was isolated through its ability to bind the SH3 
domain of the Abl non-receptor tyrosine kinase in a cDNA 
expression library screen. A short proline-rich segment in the C-
terminal tail of 3BP1 was shown to mediate binding to the Abl SH3 
(Cicchetti et al., 1992; Cicchetti and Baltimore, 1995). The protein 
SH3BP1 has a central RhoGAP domains and N-terminal BAR (Bin-
Amphiphysin-Rvs) domain that can bind and bend membranes 
(Figure I11). 
 
 
 
Figure I11: Primary structure of human SH3BP1 (701 
amino acids) contains a BAR domain, a RhoGAP domain, and a 
C-terminal tail with several proline-rich motifs (Parrini et al. 
2011). 
 
The Baltimore group (Cicchetti et al., 1995) reported that the 
central region of SH3BP1 has in vitro GAP activity for Rac and 
Cdc42, but not for Rho. Moreover in vivo experiments using Swiss 
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3T3 fibroblasts showed that: i) microinjection of the purified 
SH3BP1 GAP domain does not inhibit lysophosphatidic acid (LPA)-
induced stress fiber assembly, which is mediated by Rho in 
fibroblasts; ii) microinjection SH3BP1 GAP domain inhibits 
platelet-derived growth factor (PDGF)-induced membrane ruffling, 
which is on the contrary mediated by Rac; iii) co-injection of 
SH3BP1 with an activated mutant of Rac (RacV12) unsensitive to 
GAPs, does not inhibit RacV12-induced membrane ruffling. 
Collectively, these results suggest that SH3BP1 down-regulate Rac 
in vivo. 
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CHAPTER 2:  
REGULATION OF CELL 
MOTILITY 
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1. ACTIN AND MIGRATION 
The role of the cytoskeleton is more than simple spatial 
organization of cell content. Cytoskeleton mediates signals 
between the cell and the external environment, and plays a 
mechanical role in cell shape change and in cell motility, in 
response to these internal or external signals.      
The cytoskeleton is a dynamic structure, made of many 
proteins that can assemble and disassemble. There are three 
major kinds of protein filaments that make up the cytoskeleton: 
microtubules, intermediate filaments and actin filaments.  
We will focus on the actin because it is the most implicated 
in cell movement. In fact, actin cytoskeleton is a key regulator of 
cell migration; actin polymers form polarized structures specific 
and dynamic architectures capable to assemble into filaments that 
undergo constant disassembly into monomers; this dynamic 
polymerization maintains filament length while ensuring polarized 
growth of their fast growing ends for generation of protrusive 
forces (Carlier, 1991; Egile et al., 1999; Welch et al., 1997). 
Cell movement is a stepwise process that can be generally 
divided into four phases for the prototype mesenchymal type of 
motility, which is the most studied since it is typical of cells in the 
2D environment of culture dishes. The adhesive steps in the 
migration cycle (assembly, maturation and disassembly) are tightly 
coupled to actin polymerization and to actin–myosin contraction, 
which are in turn regulated by Rho GTPases and PTKs (Vicente-
Manzanares et al., 2009) (Figures I12A and I12B).  
First step, the cell organizes protrusive structures at the 
leading edge called lamellipodia, which is the cell portion moving 
forwards. The historical definition of “Lamellipodium” is a thin 
region at the leading edge of migrating cells, enriched in actin 
filaments and free from microtubules (Abercrombie et al., 1970, 
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Abercrombie et al., 1971) (Figure I12A). This forst sptep is 
accompagned by formation of new adhesions beneath the 
lamellipodium near the leading edge. These adhesions stabilize the 
leading edge through contact with extra cellular matrix (ECM), and 
generate signals that activate Rac and CDC42, reinforcing the 
actin polymerization at the leading edge and thus membrane 
protrusion. Second step, the cell adheres to the substrate via the 
formation of focal adhesions that anchor it to the extra cellular 
environment. Next, the nucleus is pushed forward thanks to 
traction forces generated by the adhesive structures. Finally, the 
rear of the cell retracts and the whole cell is thus moved forward. 
Nascent adhesions disassemble as the lamellipodium moves 
forwards. Actin is involved in every step of the process of cell 
motility.  Protrusive structures could be lamellipodia, but also 
filopodia, both composed of actin filaments arranged in a network 
or in bundles respectively. Adhesion to the substrate is achieved 
through the formation of focal adhesion structures that are 
connected on one end to the extracellular matrix via 
transmembrane proteins such as integrins, and to the other side 
to the stress fibers formed by actin filaments. Retraction of the 
back of the cell finally occurs through actin retraction fibers and 
acto-myosin contractility (Mattila and Lappalainen, 2008; Vicente-
Manzanares et al., 2009; Parsons et al., 2010). 
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Figure I12A: Structural elements of a migratin cell. 
Adhesion is closely coupled with the protrusions of the leading 
edge of the cell (filopodia and lamellipodia). Adhesions (nascent 
adhesions) initially form in the lamellipodium (although 
adhesions may also be associated with filopodia) and the rate 
of nascent adhesion assembly correlates with the rate of 
protrusion. Nascent adhesions either disassemble or elongate at 
the convergence of the lamellipodium and lamellum (the 
transition zone). Adhesion maturation to focal complexes and 
focal adhesions is accompanied by the bundling and cross-
bridging of actin filaments, and actomyosin-induced contractility 
stabilizes adhesion formation and increases adhesion size 
(Parsons et al., 2010). 
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Figure I12B: adhesion maturation and Rho GTPase 
activation. Nascent adhesion formation and disassembly are 
coupled with the forward movement of the lamellipodium. 
Maturation of adhesions is dependent on actomyosin in the 
lamellum, where adhesions become larger. Adhesion formation 
and disassembly in the lamellipodium is driven by the 
activation of Rac, which involves activation of the Tyr-
phosphorylated scaffolds, paxillin and focal adhesion kinase 
(FAK). In the lamellum, adhesion maturation is accompanied by 
localized activation of Rho, perhaps through FAK-dependent 
recruitment of Rho guanine nucleotideexchange factors (GEFs) 
and Rho GTPase-activating proteins (GAPs). Rho activation 
sustains the activation of myosin II through the action of Rho-
associated protein kinase (ROCK), which controls the kinases 
and phosphatases that regulate its regulatory light chain (RLC) 
phosphorylation. Myosin II-generated tension sustains adhesion 
maturation by crosslinking- and tension-induced conformational 
changes in various adhesion proteins. Disassembly of 
adhesions at the cell rear is Rho GTPase- and myosin II-
dependent, and may also involve the action of proteases, such 
as calpains, on adhesion-linked proteins. ECM, extracellular 
matrix (Parsons et al., 2010). 
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2. Rho GTPase KEY ROLE  
Cells may use different motility programs (mesenchymal, 
amoeboid, collective, etc) according to their intrinsic properties 
and to their environment. In moving cells, membrane extends 
differently depending on which motility program involved.  
In lamellipodia and filopodia, actin polymerization directly 
pushes the plasma membrane forward, whereas in invadopodia, 
actin polymerization couples with the extracellular 
metalloproteases to create a path through the extracellular matrix. 
In membrane blebbing, plasma membrane is driving forward using 
a combination of actomyosin-based contractility.  
Each membrane extension type requires the coordination of 
signaling molecules and cytoskeletal dynamics. Key signalling 
regulatory proteins in this process are the small Rho GTPases, of 
which the best characterized are Rac1, CDC42 and RhoA.  
Rho proteins (20-30 kD) are small GTPases. Most Rho 
GTPases switch between an active GTP-bound conformation, 
which interacts with downstream effectors, and an inactive GDP-
bound conformation. Guanine-nucleotide exchange factors (GEFs) 
promote the GDP\GTP exchange and thus the GTP loading of the 
protein. GTPase activating factors (GAPs) promote the GTP 
hydrolysis. Rho GTPases switch capability renders them ideal 
molecules to control changes in the cytoskeleton dynamics 
allowing a spatial and timing restricted response to extracellular 
stimuli (Heasman and Ridley, 2008). The migration process in 
general, and the formation of cellular protrusions or extensions in 
particular, are the result of the coordinated activity of Rho 
GTPases. 
Active Rac1, RhoA, and Cdc42 all localize at lamellipodia 
during protrusion (Machacek et al., 2009). Rho GTPases are 
activated by different GEFs at the leading edge, depending on the 
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cell type and extracellular stimulus (Buchsbaum, 2007). 
Regulation of Rho GTPases localization is important for their 
function. Rac is known to be recruited to at the leading edge 
through vesicle trafficking (Donaldson et al., 2009). Endocytic 
trafficking of Rac is required for Rac activation and for localized 
Rac-mediated signaling at the plasma-membrane, leading to the 
formation of actin-based protrusions (Palamidessi et al., 2008).  
Many data made strong evidence about Rac role in WRC 
activation. The first evidence came from the observation that active 
Rac was shown interacting specifically with WRC via Cyfip subunit 
(Kobayashi et al., 1998).  
Active Rac can recruite WRC complex to the 
plasmamembrane (Miki et al., 1998; Steffen et al., 2004). Active 
rac activates WRC complex through Cyfip subunit (Kobayashi et 
al., 1998). The current activation model is that WRC and is 
activated by multiple signals: Rac-GTP, acidic phospholipids, and 
a specific state of phosphorylation (Lebensohn and Kirschner, 
2009)  
 
3. RALB/EXOCYST PATHWAY IN CELL 
MIGRATION 
Few recent articles have established the existence of a 
RalB/exocyst pathway participating in the control of cell 
migration.  
It has been shown that RalA and RalB contribute differently 
to cell migration in two human cancer cell lines: UMUC-3, a 
bladder carcinoma line, and DU145, a prostate carcinoma line. 
RalA depletion had no effect on cell migration, but RalB depletion 
reduces migration in these cells, using an in vitro Transwell 
migration assay. Simultaneous depletion of RalA and RalB had no 
effect on migration. This indicates that RalA and RalB have 
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nonoverlapping functions in cell motility. The authors proposed 
the two Ral proteins have antagonist effects, with RalB being 
promigratory and RalA a motility-inhibitor. This antagonism may 
reflect the importance of intracellular protein localization in cell 
motility (Oxford et al., 2005).  
Consistently, in our laboratory, it was found that, in non-
transformed NRK (Normal Rat Kidney) cells, depletion of RalB, but 
not RalA, inhibits cell migration using in vitro wound-healing 
assays.  Again, cells depleted of both RalA and RalB migrate 
normally (Rosse et al., 2006). 
In agreement with these in vitro findings, a specific role for 
RalB in invasion and metastasis was shown in vivo by mouse tail-
vein injection assay using a panel of ten genetically diverse human 
pancreatic cancer cell lines. When RalB was depleted in the 
injected cells, the formation of metastasis in the mouse lungs was 
reduced (Lim et al., 2006). 
Whereas a role of Ral GTPases in migration was 
demonstrated, the underlying mechanistic basis has remained 
elusive. Ral has two well-documented effectors RLIP76/RalBP1 
and exocyst, which may link Ral to actin dynamics and membrane 
traffic. RalBP1, is a Rac/CDC42 GAP implicated in the functional 
assembly of endocytosis machinery (Jullien-Flores et al., 2000; 
Nakashima et al., 1999). The exocyst complex regulates exocytosis 
to regions of rapid membrane expansion (Brymora et al., 2001 ; 
Sugihara et al., 2001 ; Polzin et al., 2002 ; Moskalenko et al., 
2002 ; Moskalenko et al., 2003). 
The molecular mechanistic basis for this role of RalB in cell 
migration has been addressed, and is still under investigation, in 
our laboratory.   
In our system, the RLIP76/RalBP1 effector pathway is not 
limiting for cell motility, which was somehow surprising since the 
RhoGAP RalBP1 protein can directly inactivate Rac and Cdc42.  In 
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contrast, the exocyst was found to be required, suggesting that 
RalB controls cell motility via its exocyst effector. Indeed, RalB was 
shown both to stabilize the assembly of the full heteromeric 
exocyst complex and to localize functional exocyst complexes to 
the leading edge (Rosse et al., 2006). 
Cell migration requires de novo plasma membrane addition 
at the leading edge, and a driving role of vesicle trafficking in 
directional cell motility has been suggested long time ago 
(Bretscher and Aguado-Velasco, 1998). Presumably, RalB/exocyst 
pathway is implicated in the regulation of dynamic membrane 
expansion in motile cells by coordinating delivery of secretory 
vesicles to the sites of dynamic plasma membrane expansion that 
specify directional movement. The secretory vesicles in motile cells 
may as well carry regulators that are delivered at the leading edge, 
where they may participate in locally regulating the actin and 
adhesion dynamics. To this regard, the molecular actors and 
connectivities are largely unknown.    
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1. CELL LINES AND CULTURE 
NRK (Normal Rat Kidney), HEK-HT (Human Embryonic 
Kidney cells stably expressing the early region of SV40 and the 
catalytic subunit of telomerase hTERT) and human 293T cell lines 
were grown in Dulbecco’s modified Eagle’s medium (DMEM, Life 
Technologies, Inc.) supplemented with 10% fetal bovine serum, 
100 units/ml penicillin/streptomycin and 2mM L-Glutamine, at 
37°C and 5% CO2 in humidified incubator on plastic dishes. 
High Five (H-5) Trichoplusia ni cell line was grown in Express 
Five medium (Invitrogen) supplemented with 2mM L-Glutamine at 
27°C in suspension at 100rpm.  
E.coli BL21 cells (Promega) were grown in LB medium at 37° 
at 200rpm. 
 
2. PLASMIDS AND siRNA OLIGONUCLEOTIDES 
 
2.1. Plasmids 
SH3BP1 WT (aa 1–701), DBAR (aa 255–701), DCter (aa 1–
466) were expressed using pcDNA3 mammalian expression vector.  
YFP-Abi Abi1FL (aa 1-476), YFP-Abi DN (aa 145-476), YFP-
AbiN (aa 1-145) were expressed using pCMV mammalian 
expression vector.  
GST-Exo70 and GST-Sec6 were expressed using pGEX4T 
bacterial expression vector. 
GST-Abi1, GST- 535-821 EPS8 and GST-648-821 EPS8 were 
expressed using pGEX6P1 bacterial expression vector.  
 
2.2. siRNAs 
siRNAs were ordered from Eurogentec. Targeted sequences are: 
 
siLuciferase   TACGCGGAATACTTCGA 
siUSP9X  CCGCCAGATAGCACAACGATA 
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siRalB     AAGAGCCCAGTATTCACATTT (Cascone et al., 2006) 
siRalA     GACAGGTTTCTGTAGAAGA (Cascone et al., 2006) 
siSec5     GGGTGATTATGATGTGGTT (Kashatus et al., 2011) 
siSec6     ACCTCCTGAACATGTACCA (Sakurai-Yageta et al., 2008) 
siSec8     AATCGACTAGCCGAGTTGT (Sakurai-Yageta et al., 2008) 
siExo70   CCAAGATTTCATGAACGTCTA (Misselwitz et al., 2011) 
siExo84   GCCACTAAACATCGCAACT  
siAbi1      TCTCTAGCTAGTGTTGCTT  
siWave2   AGTCACTCAGCTGGATCCC 
siCyfip1    GTACTCCAACAAGGACTGC 
siSH3BP1-1 Rat  GCCTTAGAGATGAGCTGTG (Parrini et al., 2011) 
siSH3BP1-2 Rat  GAGAAAGGTGGAACAGTGC (Parrini et al., 2011) 
siβPIX Rat     GGGTTCGATACGACTGCCA (Parrini et al., 2011) 
siRalB Rat     TGACGAGTTTGTAGAAGAC (Parrini et al., 2011) 
siSec5 Rat     GGTCGGAAAGACAAGGCAGAT (Parrini et al., 2011) 
siSec8 Rat     GGTCCTGATGACAACTTAA (Parrini et al., 2011) 
siExo84 Rat   TGGGCATGTTCGTGGATGC (Parrini et al., 2011) 
 
3. WESTERN BLOT 
 
3.1. Preparation of cell lysates  
After washing with PBS 1x, cells were lysed directly in the 
plates using a cell-scraper, in cold lysis buffer (50 mM TrisHCl (pH 
7.5), 150 mM NaCl, 1% Triton, 1mM EDTA freshly supplemented 
with protease inhibitor mixture (Roche) and 1 mM dithiothreitol). 
Lysates were incubated on ice for 10 minutes and centrifiuged at 
13000 rpm for 10 min at 4ºC. The supernatant was transferred 
into a new tube.  
 
3.2. Electrophoresis, Transfer, Immunoblotting  
Desired amounts of proteins were loaded into 10% or 15% 
1.5-mm thick polyacrylamide gels for electrophoresis (Biorad). 
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Proteins were transferred in Western transfer tanks (Biorad) to 
nitrocellulose membrane (Amersham) in Western Transfer buffer 
1x (25 mM Tris, 192 mM glycine, 20% ethanol). Ponceau coloring 
was used to reveal the proteins transferred on the membrane. 
Membrane was blocked 1 hour in 5% BSA in TBS 0.1% Tween 
(TBS-T). After blocking, membrane was incubated with the primary 
antibody, diluted in TBS-T 1% BSA, for 1 hour at room 
temperature, or over night at 4˚C, followed by three washes of five 
minutes each in TBS-T and then incubated with the appropriate 
horseradish peroxidase-conjugated secondary antibody diluted in 
TBS-T 1% BSA, for 1 hour. After the incubation with the 
secondary antibody, membrane was washed three times in TBS-T, 
and the bound secondary antibody was revealed using the ECL 
(Enhanced Chemiluminescence) method (PerkinElmer).  
 
4. ANTIBODIES  
Anti-Sec6 mouse monoclonal (Stressgen). 
Anti-Sec5 and anti-Exo84 rabbit polyclonal (gift from Dr Yeaman). 
Anti-RalA, anti-Sec8 and anti-bPix mouse monoclonal (BD 
transduction). 
Anti-RalB rabbit polyclonal (Cell Signalling Technology). 
Anti-Cyfip1 and anti-Nap rabbit polyclonal (Upstate) 
Anti-USP9X mouse monoconal (Abcam). 
Anti-pericentrin rabbit polyclonal (Covance). 
Anti-Abi1 mouse monoclonal (generated against human Abi1 aa 
417-448, C-terminus, Scita group. 
Anti-Wave2 mouse monoclonal (generated against human Wave2 
aa 422-498, VCA domain, Scita group. 
Anti-Wave2 rabbit polyclonal (gift from Dr Gautreau). 
Anti-SH3BP1 goat polyclonal (Everest Biotech).  
Anti-SH3BP1 rabbit polyclonal (Atlas). 
Anti-SH3BP1 rabbit polyclonal (gift from Dr Cicchetti).  
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Anti-HA rat monoclonal (3F10) (Roche). 
Mouse monoclonal anti-GST, anti-Myc (E910) and anti-FlagM2 
(IFOM-IEO Campus Antibody facility). 
Mouse monoclonal anti-actin, anti-FlagM2, anti-GFP and beads 
coupled with FlagM2 antibody (Sigma).   
Beads coupled with GFP antibody (ChromoTek). 
Western blot secondary antibodies were horseradish peroxidase-
conjugated (Jackson ImmunoResearch and Molecular Probes). 
Immunofluorescence secondary antibodies coupled with Alexa-
488, Alexa-546 or Cy5 (Invitrogen). 
 
5. DNA AND siRNA TRANSFECTIONS 
 
5.1. DNA transfection  
Transfections were performed using either calcium 
phosphate or Lipofectamine Plus reagents (Invitrogen).  
 
5.1.1. Calcium phosphate DNA transfection 
293T cells were transfected using the calcium phosphate 
procedure. In this case DNA (20 µg for a 15-cm dish) was diluted 
in 878 µl of ddH2O and 122 µl of 2M CaCl2 were added. This 
solution was added, drop-wise, to 1mL of HBS 2x (50 mM Hepes 
pH 7.5, 10 mM KCl, 12 mM dextrose, 280 mM NaCl, 1.5 mM 
Na2HPO4). After 10 minutes incubation, the precipitate was added 
drop-wise to the cells and removed after 12-16 hours.  
This transfection was used for the experiments with the 
FlagNap/myc-Cyfip subcomplex.  
5.1.2. Lipofectamine Plus DNA transfection 
At day 0, cells were plated into appropriate dishes (12-wells, 
6-cm or 10-cm dishes) in complete DMEM medium. According to 
manufacturer’s instructions, at day 1, two mixtures were prepared 
and incubated 10 minutes: Mix1 (DNA and Plus reagent in OPTI-
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MEM medium) and Mix2 (Lipofectamine in OPTI-MEM medium). 
Afterwards, these two Mix were mixed together, and incubated 
additional 10 minutes. Mix1+Mix2 was than added to cells in 
OPTI-MEM. 3h later, medium was changed to complete medium. 
At day 2-3, 24-48 hours after transfection, cells are fixed or lysed. 
 
5.2. siRNA transfection 
Reverse transfection method was used to transfect cells by 
siRNA, using Hiperfect (QIAGEN), according to manufacturer’s 
instructions. At day 0, a mix of siRNA at a final concentration of 
10nM is prepared in 100uL OPTI-MEM with 6uL Hiperfect reagent. 
After 10 minutes of incubation at room temperature, the mix is 
added to freshly plated cells in 12-wells in complete medium. At 
day 1, medium is changed. At day 3, 72 hours after transfection, 
cells are used in experiments.  
 
6. IMMUNOFLUORESCENCE 
Cells were fixed with 4% paraformaldehyde (in PBS) for 10 
minutes, washed with PBS and permeabilised in PBS 0.1% Triton 
X-100 for 10 minutes at room temperature. To prevent non-
specific binding of the antibodies, cells were saturated with PBS 
supplemented with 10% Fetal Bovine Serum (FBS) for 1 hour and 
incubated with the indicated antibodies in PBS-FBS 10% for 1 
hour. After 3 washes of 5 minutes with PBS, cells were incubated 
with appropriate secondary antibodies coupled with Alexa-488 or 
Alexa-546 or Cy5 in PBS-FBS 10% for 1 hour. After 3 washes of 5 
minutes with PBS, cells were mounted with Prolong (Invitrogen) 
and examined by fluorescence microscopy. 
 
7. IMMUNOPRECIPITATION 
 
7.1. Immunoprecipitation buffers 
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Buffer1: Sec8 and YFP immunoprecipitations (50 mM 
TrisHCl (pH 7.5), 150 mM NaCl, 1% Triton, 1mM EDTA freshly 
supplemented with protease inhibitor mixture (Roche) and 1 mM 
dithiothreitol). 
 
Buffer2: HA immunoprecipitation (20 mM Tris HCl (pH 7.5), 
100 mM NaCl, 5 mM MgCl2, 1% Triton, 10% glycerol, freshly 
supplemented with protease inhibitor mixture (Roche) and 1 mM 
dithiothreitol). 
 
Buffer3: Flag and V5 immunoprecipitations (50 mM Tris HCl 
(pH 7.5), 150 mM NaCl, 1% Triton, 0.1% Sodium dodecyl sulfate 
(SDS), 0.5% Sodium deoxycholate (DOC), 1mM EDTA, 5% glycerol, 
freshly supplemented with protease inhibitor mixture (Roche) and 
1 mM dithiothreitol). 
 
Buffer4: Washing buffer low salt (10 mM Tris HCl (pH 7.5), 
Sodium dodecyl sulfate (SDS) 0.1%, Sodium deoxycholate (DOC) 
1%, EDTA 5mM, glycerol 5%, freshly supplemented with protease 
inhibitor mixture (Roche) and 1 mM dithiothreitol) and Washing 
buffer high salt (Low salt buffer + 500 mM NaCl). 
 
7.2. Immunoprecipitation/purification from 293T cells 
 
7.2.1. Sec8 immunoprecipitation (Figure R11 C)  
One 10-cm dish of DNA-transfected 293T cells was lysed 
into 1ml buffer1. Supernatant was incubated 2h rocking at 4°, 
with 25ul of beads covalently coupled to a mixture of monoclonal 
anti-Sec8 antibodies (Yeaman et al., 2001). The immobilized 
immune complexes were washed three times with 1 ml of the same 
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buffer. Samples were boiled and analyzed by SDS-PAGE. 1.6% 
input was loaded. 
 
7.2.2. HA immunoprecipitation (Figure R11 D and E) 
One 6-cm dish of DNA-transfected 293T cells was lysed in 
600ul buffer2. Supernatant was incubated 1h rocking at 4°, with a 
monoclonal anti-HA antibody (3F10, 1ug). The immobilized 
immune complexes were washed three times with 1 ml of the same 
buffer. Samples were boiled and analyzed by SDS-PAGE. 6% input 
was loaded. 
 
7.2.3. YFP immunoprecipitation (Figure R9) 
One 6-cm dish of DNA-transfected 293T cells was lysed in 
600ul buffer1. Supernatant was incubated 1h rocking at 4°, with 
20ul magnetic beads coupled to GFP antibody (ChromoTek). This 
“GFP trap” functions also as a YFP trap. The immobilized immune 
complexes were washed three times with 1 ml of the same buffer. 
Samples were boiled and analyzed by SDS-PAGE. 1.5% input was 
loaded. 
 
7.2.4. V5 immunoprecipitation (Figure R6) 
I used 5x15-cm dishes per condition. Each 15-cm dish was 
lysed into 1ml buffer3. Supernatant of 5 dishes was incubated 1h 
rocking at 4°, with 10ug anti-V5. 1h later, 20ul magnetic G-protein 
beads (Invitrogen) were added for 1h. The immobilized immune 
complexes were washed three times in high salt buffer and three 
times in low salt buffer. Samples were boiled and analyzed by 
SDS-PAGE. 1% input was loaded.  
 
7.2.5. Flag immunoprecipitation/purification of WRC 
complex (Figure R4, R5, R7 and R8) 
74 
 
I used 5x15-cm dishes per condition for in vivo association 
experiments, and 10x15-cm dishes per condition for in vitro 
interaction assay. Each 15-cm dish was lysed in 1ml buffer3. 
Supernatant of 5/10 dishes was incubated 2h rocking at 4°, with 
20/40ul magnetic beads coupled to FlagM2 antibody (Sigma). The 
immobilized immune complexes were washed three times in high 
salt buffer and three times in low salt buffer. For in vivo 
experiments, samples were boiled and analyzed by SDS-PAGE. 1% 
input was loaded. For in vitro experiments, beads were kept into 
buffer5.  
 
7.2.6. Purification of Flag-Nap/Myc-Cyfip subcomplex 
(Figure R3) 
I used 20x15-cm dishes per condition. Each 15cm dish was 
lysed in 1ml buffer3. Supernatant of 20 dishes was incubated 2h 
rocking at 4°, with 10ug anti-FlagM2 (Sigma). 1h later, 20ul 
magnetic G-protein beads (Invitrogen) were added for 1h. The 
immobilized immune complexes were washed three times in high 
salt buffer and three times in low salt buffer and kept into buffer5.  
 
8. PROTEIN PURIFICATION FROM BACTERIA OR INSECT 
CELLS 
 
8.1. Protein production using E.coli  
 
8.1.1. Transformation of competent cells 
E.coli Top10 cells (Invitrogen) were used for cloning and large 
scale DNA preparation, while E.coli BL21 cells (Promega) were used 
for protein production. The transformation protocol used was the 
same for both strains. 
50 l of fresh competent cells were thawed on ice for 
approximately 10 minutes prior to the addition of plasmid DNA. 
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Cells were incubated with DNA on ice for 20 minutes and then 
subjected to a heat shock for 45 seconds at 42°C. Cells were then 
returned to ice for 2 minutes. Then, 0.4 ml of LB were added and 
the cells were left at 37°C for 60 minutes before plating them onto 
plates with the appropriate antibiotic. 200 l of the transformed 
bacterial were usually plated. Plates were incubated overnight at 
37°C. 
 
8.1.2. Protein expression 
A one-day miniculture of transformed E.coli BL21 is grown 
overnight in 1L prewarmed LB with ampicillin selection 
(100ug/mL) at 37° 200rpm. The overnight culture is diluted 1:50 
in ampicillin-LB and grown till OD 0.6. Bacteria are cooled, IPTG 
added (0.5mM) and grown 4h at 25° 200rpm. Bacteria were 
pelleted and kept at -80°.  
 
8.1.3. Protein purification buffers 
 
Buffer6: Purification buffer (50 mM Tris HCl (pH 7.8), 500 
mM NaCl, 1% Triton, 5% glycerol, freshly supplemented with 
protease inhibitor mixture (Roche) and 1 mM dithiothreitol). 
 
Buffer7: Purification washing buffer which is purification 
buffer without Triton. 
 
Buffer8: Dialysis buffer (50 mM Tris HCl [pH 7.5], 150 mM 
NaCl, 5% glycerol, freshly supplemented with protease inhibitor 
mixture (Roche) and 1 mM dithiothreitol). 
 
8.1.4. Purified proteins 
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Pellet is resuspended in buffer6 (20mL for 1L bacteria), 
sonicated (3x30 seconds) and centrifuged (10000rpm, 45min at 
4°). Supernatant is incubated 2h on a rotating wheel at 4° with 
Glutathione beads (Thermo scientific) (200ul dry beads for 1L 
bacteria), previously washed 3 times with buffer7. After that, 
beads are extensively washed with buffer7.  
Using this method, the following proteins were produced: 
GST-Exo70, GST-Sec6, GST-SH3 EPS8 (535-821 EPS8 containing 
SH3 domain) and GST-Cter EPS8 (648-821 EPS8 C-terminus 
fragment). 
For some experiments the proteins were kept on beads for 
following binding experiments. When indicated, in order to obtain 
soluble proteins, elution was performed using three 10-min 
rounds of incubation in buffer7 supplemented with 50mM 
Glutathione. pH was adjusted. Overnight dialysis was then 
performed in buffer8. 
While GST-tag EPS8 fragments were abundantly purified 
(0.5 L bacteria gave about 400-600ug protein); the production 
yield of GST-Exo70 and GST-Sec6 was poor (1L bacteria gave 
about 5-15ug protein). 
 
8.2. Protein production using Baculovirus  
 
8.2.1. Transfection of insect cells 
 
Isolation of recombinant DNA:  
DH10 MultiBac-YFP electro-competent E.Coli were thawed 
on ice few minutes prior to the addition of plasmid DNA. 
Electroporation was performed. Then, 0.9 ml of LB were added and 
the cells were rotated at 37°C for 4h before plating them onto 
plates with the appropriate antibiotic. After 48h incubation at 
37°C, white colonies (containing DNA of interest) were isolated and 
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incubated overnight at 37° in new plates. Clones were grown to 
stationary phase in 2mL LB by shaking at 200rpm and cells were 
collected by centrifugation. Minipreps were realized (QIAprep Spin 
Miniprep Kit, QIAGEN). 
 
Transfection of High Five (H-5) cells: 
A mix of Bacmid DNA, Express Five medium and 
INSECTOGENE transfection reagent (Biontex) was prepared and 
incubated 20 minutes. This mix is added to H-5 cells seeded in the 
meantime in 6-well plates, and incubated 5h at 27° without 
shaking. Then, medium is changed and cells are incubated 72h at 
27°. Since Bacmid contains the gene for YFP expression, 
transfection can be checked by fluorescence microscopy. After 10-
min centrifugation at 1000rpm, supernatant is the primary viral 
stock (V0). V0 can be stored in the dark at 4°. 
 
Amplification of primary viral stock (generation of V1 virus): 
A shaker flask with 25mL H-5 cells at 0.5x105 cell/ml 
density is prepared. 2mL of V0 is added and cells are cultured for 
72h. Cell division stop shows virus infection efficiency. After 10-
min centrifugation at 1000rpm, supernatant is the secondary viral 
stock (V1). V1 can be stored in the dark at 4°.  
 
8.2.2. Protein expression 
A shaker flask with 200mL H-5 cells at 0.5x105 cell/ml 
density is prepared. 2mL of V1 is added and cells are cultured for 
72h. After 10-min centrifugation at 1000rpm, pelleted cells will be 
used for protein purification. 
 
8.2.3. Protein purification 
Pellet is resuspended in buffer6 (10mL for 1L H-5 cells), 
sonicated (3x10 seconds) and centrifuged (5000rpm, 45min at 4°). 
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Supernatant is incubated 2h on a rotating wheel at 4° with 
Glutathione beads (Thermo scientific) (200ul dry beads for 1L 
bacteria), previously washed 3 times with buffer7. After that, 
beads are extensively washed with buffer7.  
Abi1 was purified using this method. GST-Abi was produced 
and cleaved on the beads by addition of GST-PreScission protease 
(1ug protease for 100ug recombinant protein, overnight on a wheel 
at 4°). Overnight dialysis is then performed in buffer8. 1L H-5 cells 
gave 20-50ug cleaved Abi protein. 
 
9. IN VITRO PROTEIN INTERACTION ASSAY 
 
Buffer used in these experiments was In vitro interaction 
buffer (buffer5) (50 mM Tris HCl (pH 7.5), 150 mM NaCl, 1% 
Triton, 5% glycerol, freshly supplemented with protease inhibitor 
mixture (Roche) and 1 mM dithiothreitol). 
 
9.1. Abi  - GST-Exo70 (Figure R2) 
30ug Abi was incubated in 300 ul buffer5 for 2h rocking at 
4°, with 30ug GST-Exo70 or with beads alone, GST-Cter EPS8 or 
GST-SH3 EPS8 as controls. After, beads were washed three times 
in high salt buffer and three times in low salt buffer. Samples were 
boiled and analyzed by SDS-PAGE. 5% input was loaded. 
 
9.2. Flag-tag WRC complex – GST-Exo70/GST-Sec6 
(Figure R5) 
Bead-bound Flag-tag WRC complex (Flag-HA-Abi, Flag-HA-
Cyfip or Flag-HA control) purified from 20x15-cm dishes was 
incubated in 300 ul buffer5 for 2h rocking at 4°, with 10ug GST-
Exo70, GST-Sec6 or GST as control. Afterwards, beads were 
washed three times in high salt buffer and three times in low salt 
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buffer. Samples were boiled and analyzed by SDS-PAGE. 5% input 
was loaded.  
 
9.3. Flag-Nap/Myc-Cyfip subcomplex – GST-Sec6 (Figure 
R9) 
Bead-bound Flag-tag proteins (Flag-Nap/Myc-Cyfip or Flag-
Nap and Flag-AEK as control) purified from 30x15-cm dishes were 
incubated in 300 ul buffer5 for 2h rocking at 4°, with 20ug GST-
Sec6 or GST-Exo70 as control. Afterwards, beads were washed 
three times in high salt buffer and three times in low salt buffer. 
Samples were boiled and analyzed by SDS-PAGE. 5% input was 
loaded.  
 
10. WOUND HEALING ASSAY AND TIME-LAPSE 
MICROSCOPY 
Cells were grown to confluence on dishes coated with 
collagen (type I from rat tail, Interchim) and the monolayer was 
wounded with a tip. Medium was changed to MEM with 2% fetal 
bovine serum.  
For phase-contrast video microscopy, images were acquired 
with 10x objective every 15 min.  
To track cells, I used Manual Tracking plug-in (developed by 
Fabrice Cordelières) of the ImageJ software (Rasband, W.S., 
ImageJ, National Institutes of Health, Bethesda, Maryland, USA, 
http://rsb.info.nih.gov/ij/, 1997-2003). Persistence of motility was 
calculated as the D/T ratio, where D is the direct distance from 
startpoint to endpoint and T is the total track. 
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1. PROJECT HYPOTHESIS 
In our laboratory, it was established that RalB controls cell 
motility via the exocyst (see Introduction). The Rac1 GTPase is, on 
the other hand, a key player in regulating actin dynamics that 
propels cell motility process (see Introduction). 
Therefore, we hypothesize the existence of molecular links 
connecting the RalB/exocyst and Rac1 pathways. To identify these 
possible connections, we analyzed the data coming from screening 
previously performed in the laboratory with the aim to define the 
Ral pathway interactome.  
 
2. EVIDENCE FOR AN EXOCYST-WRC CONNECTION 
Three different screenings previously realized in our group 
identified molecular connections between the Ral pathway and the 
WRC complex. 
2.1 MOLECULAR SCREENING (YEAST TWO-HYBRID) 
A series of two-hybrid screenings using human exocyst 
subunits as baits, performed in collaboration with the Hybrogenics 
company, highlighted two potential connections between the 
exocyst complex and the Wave regulatory WRC complex: the Sec6 
exocyst subunit interacted with Cyfip, while the Exo70 exocyst 
subunit was found to associate with Abi1 (Figure R1 A).  
In the case of the Sec6-Cyfip interaction, a 297-745aa 
fragment of human Sec6 (NCBI, NP_848611.2) was used as bait 
and the 325-507aa Cyfip (NCBI, NP_055423.1) fragment was 
recovered from the screening. Notably, this region overlaps with 
the RacGTP interaction domain of Cyfip (aa 1-407) (Kobayashi et 
al., 1998) (Figure R1 B).  
In the case of Exo70-Abi1 complex, the full length human 
Exo70 (NCBI, NP_001013861.1) was used to fish out a 36-216aa 
fragment of Abi1 (NCBI, NP_001012770.1). This latter region 
encompasses the amino-terminal coiled-coil domain of Abi1 that 
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was shown to interact directly with Wave2 (aa 1-111) (Leng et al., 
2005) (Figure R1 C).  
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Figure R1: Two-hybrid interaction results. (A) Simplified 
subunit interactions between exocyst and WRC. Arrows 
show Exo70-Abi and Sec6-Cyfip interactions. (B) Sec6-Cyfip 
interaction. Human Sec6 (297-745), used as bait, fished out a 
Cyfip fragment (325-507). This domain overlaps with the 
interaction region of Cyfip with RacGTP (1-407). (C) Exo70-Abi 
interaction. Full length human Exo70, used as a bait, fished 
out the N-terminal 36-216 Abi fragment, which includes the 
Wave2 interacting domain of  Abi1 (1-111). In Abi1: Blue domain 
is coiled coil, Green domain is SH3. (D) Primary structure of 
SH3BP1 and results of two-hybrid. Human SH3BP1 protein 
is composed of 701 amino acids. It contains an N-terminal BAR 
domain, a central RhoGAP domain, and a C-terminal tail rich of 
prolins. Dark lines indicate minimal interaction domains with 
Sec8 and Exo84 resulting from two-hybrid assay. 
 
2.2 GENETIC SCREEN IN DROSOPHILA 
Drosophila melanogaster in vivo model was used to compile a 
catalogues of the Ral-based network. The fruit fly system provides 
the advantage with respcet to vertebates to possess a single Ral 
gene, whose protein product shares 80% of homology with 
mammalian RalA and RalB. Furthermore, the protein network 
upstream and downstream of Ral is largely conserved between 
human and flies (Mirey et al., 2003).  
Decreasing Ral activity by overexpression of dominant-
negative form of Ral or by using Ral hypomorphic loss-of-function 
mutations induced a highly penetrant loss-of-bristle phenotype 
due to post-mitotic cell-specific apoptosis during bristle 
development (Balakireva et al., 2006).  Each wild type bristle, the 
fly sensory organ, is composed of four cells with different 
developmental programs. When the activity of Ral is decreased 
many sensory organs are defective and contain only three cells as 
a result of the apoptotic death of one of the cells in the sensory 
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organ lineage. This defect in sensory organ organization leads to 
Ral-dependent loss-of-bristle phenotype.  
This Ral apoptotic loss-of-bristle phenotype was then used 
to identify new molecular players in Ral signaling. A gain-of-
function screen of 1188 Drosophila genes was performed in our 
laboratory, by Claire Beraud and Maria Balakireva, to determine 
potential Ral interacting partners according to the  strategy 
outlined below: (i) both the dominant negative form of Ral and the 
wild type form of the protein for each tested gene were co-
expressed in the sensory organ cells, (ii) the bristle phenotypes 
resulting from each Ral genetic interaction were then compared to 
the control Ral loss-of–bristle phenotype; (iii) suppressors or 
enhancers of Ral apoptotic bristle phenotype were identified. Both 
enhancers (577) and suppressors (179) were found as potential Ral 
partners. Among those, 50 genes are involved in cell cycle, 
programmed cell death, migration, trafficking or adhesion 
processes. (Beraud and Balakireva, Camonis group, unpublished 
data).  
Notably, a component of the WRC, Cyfip (which is named 
Sra in Drosophila) was identified as a potential Ral partner since 
its overexpression enhanced Ral apoptotic phenotype. 
 
2.3. FUNCTIONAL SCREENING ON CYTOKINESIS IN HeLa 
CELLS 
The last step of cell division is called cytokinesis, during 
which physical separation of dividing daughter cells occurs.  
The implication of the exocyst as a Ral effector in the 
abscission of the intracellular bridge had already been established 
(Gromley et al., 2005). Moreover, a previous project in our 
laboratory had showed that depletion of RalA or RalB by siRNAs in 
three cell lines [HeLa, HBEC (human bronchiolar epithelial cells) 
and HEK-HT (human kidney epithelial cells)] resulted in 
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cytokinesis defects, which were different depending on the Ral 
protein that was interefered. RalA depletion causes the 
accumulation of binucleate cells. The cleavage furrow is still able 
to form the intracellular bridge, but the intracellular bridge is no 
longer stable. Daughter cells are arrested before completion of 
cytokinesis and fused back to form a single cell with two nuclei. 
RalB depletion frequently causes, instead, the appearance of cells 
connected by an intracellular bridge because cells are no longer 
able to cleave the intracellular bridge (Cascone et al., 2008). 
Collectively, these findings indicate that RalA and RalB have 
distinct roles in two different steps of cytokinesis. RalA is in 
involved in early, while RalB in late cytokinesis steps. 
In order to identify new actors of Ral GTPases cytokinesis 
pathway, a functional screening using interfering RNA was carried 
out in in HeLa cells, in collaboration with Biophenics Laboratory. 
91 genes implicated in proteasome process, cell cycle, cytoskeleton 
regulation, protein transport, and potentially involved in Ral 
interactome where targeted by siRNAs. The results showed that 
depletion of 14 proteins, among the 91 tested, phenocopied the 
binucleated cell phenotype of RalA, whereas depletion of 8 proteins 
caused the same defective cleavage of the cytokinetic bridge as 
RalB-depleted cells (Rasim Selimonglu and Ilaria Cascone, 
Camonis group, unpublished data). 
Abi, a component of WRC, was identified among the latter 
proteins. Abi depletion caused a significant accumulation of cells 
that cannot complete abscission and remain connected by 
intracellular bridges.  
 
3. EVIDENCE FOR AN EXOCYST-SH3BP1 CONNECTION 
 
3.1. SH3BP1 WAS FISHED OUT THROUGH THE EXOCYST 
TWO-HYBRID SCREENING 
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In the two-hybrid screening for exocyst partners described 
above, both Sec8 and Exo84 subunits fished out the SH3BP1 
protein, a signaling adaptor possessing a Bar and Rac GAP 
domains in addition to a prolin-rich C-terminal tail (Parrini et al., 
2010) (see Introduction).  
SH3BP1 presumably interact with both Sec8 and Exo84 via 
its Bar domain as suggested by the finding that the smallest fished 
SH3BP1 fragments encompassed amino acids  65-257 (for Sec8 
screen) and 79-255 (for Exo84 screen) (Figure R1 D). 
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CHAPTER 2:  
MOLECULAR AND FUNCTIONAL 
LINKS BETWEEN EXOCYST 
AND WRC 
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1. BIOCHEMICAL STUDIES OF THE EXOCYST-WRC 
INTERACTION 
 
1.1. WRC DIRECTLY INTERACTS WITH EXOCYST 
To confirm the Exo70-Abi1 and Sec6-Cyfip interactions 
identified by the two-hybrid screening, I performed in vitro 
interaction assays using purified proteins.  
 
1.1.2. Abi interacts in vitro with Exo70 
I purified Abi1 from H-5 insect cells (High 5 cells derived 
from Trichoplusia ni). To this end, I infected H-5 cells with baculo 
virus expressing GST-tag, full length human Abi1 (isoform a), 
which was subsequently purified using glutathione-coupled beads 
and recovered after cleaving Abi1 protein with PreScission protease 
(see Materials and Methods) (Figure R2 A). 
Full-length Exo70 protein was, instead, expressed as GST-
fusion in E.coli and purified using glutathione-coupled beads.   
As control, I used GST-fused fragments of EPS8 (Epidermal 
Growth Factor Receptor Pathway Substrate 8) which have been 
previously shown to either mediated or not the interaction with Abi 
(Biesova et al., 1997; Scita et al., 2001). More specifically, the 
EPS8 SH3 domain was identified as the portion mediating the 
interaction with Abi1 and was therefore used as positive control of 
the experiment. The EPS8 C-terminus, which was shown to bind 
actin but not Abi1 was used as negative control of the experiment. 
An additional negative control is represented by protein-free 
glutathione beads. 
I incubated bead-bound GST-Exo70, GST-SH3-EPS8 and 
GST-C-ter-EPS8 with GST-cleaved Abi.  After 1 hour of incubation 
of rotatory device at 4º C, (see Materials and Methods), I separated 
beads by centrifugation before separating the bound proteins by 
SDS-PAGE followed by western blotting with specific antibodies.  
90 
 
Ponceau red staining of the nitrocellulose membrane shows 
that similar amounts of pure bead-bound GST-Exo70, GST-SH3 
EPS8 and GST-Cter EPS8 were employed.  
Immunoblotting with anti-Abi1 antibody shows, instead, 
that Abi1 binds with similar apparent affinity both GST-SH3 EPS8 
and GST-Exo70, but not GST-Cter EPS8 (Figure R2 B).  
Thus, Abi1 directly associates with Exo70 with an affinity 
comparable to that of the Abi1-EPS8 complex.  
 
91 
 
 
 
Figure R2. Abi interacts invitro with Exo70. (A) Abi 
purification. Coomassie staining showing on the left bead-
Bound GST-Abi1 purified from H5 cells, on the right GST alone, 
and cleaved Abi1. (B) Abi pull down. Abi protein was purified 
from insect cells; GST-Exo70, GST-Cter EPS8 (negative control) 
and GST-SH3 EPS8 (positive control) were purified from E.Coli. 
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Ponceau red shows GST-tag proteins. Abi was incubated with 
GST-tag proteins, and then pulled down. Abi1 western blot 
shows Abi interacting with the positive control and equally well 
with GST-Exo70. 5% of the Abi input was loaded. The perturbed 
Abi1 bands pulled down by the SH3 domain of Eps8 is 
presumably due to the fact the the two proteins runs very 
closely in SDS-PAGE. Abi1 runs at around 55-65 KDa; and the 
molecular weight of GST-535-821 fragment of EPS8 that was 
used is 57KDa (EPS8SH3 31KDa + GST 26KDa).   
 
1.1.3. Cyfip interacts in vitro with Sec6 
To validate the Sec6-Cyfip interaction, I had to make sure to 
preserve the stability and the correct folding of the labile and 
poorly soluble Cyfip protein. To this end I used an already reported 
strategy (Innocenti et al., 2004): I coexpressed Cyfip with its major 
interactor Nap1. The two proteins form a relatively stable 
subcomplex which is normally incorporated into a large WRC unit. 
A Myc-Cyfip expressing vector, together with a Flag-Nap1 
expressing vector, were cotransfected in 293T cells. As control, I 
also transfected Flag-Nap1 vector alone, as well as a non-related 
Flag-tag protein: AEK (catalytically-dead GEF Arno). I affinity 
purified Flag-tag proteins using Flag antibody bound onto beads. 
Purified and soluble GST-Sec6 and GST-Exo70 (which I used as 
negative soluble control) from E.Coli (see Materials and Methods) 
were subsequently incubated for 1 hour with immobilized Flag-tag 
proteins. Bound material, separated by SDS-PAGE, was 
immunoblotted with specific antibodies 
Ponceau red staining of the nitrocellulose membrane shows 
that similar amounts of pure and soluble GST-Exo70 and GST-
Sec6 were used as well as of immobilized Flag-AEK, Flag-Nap1 
expressed alone and Flag-Nap1 co-expressed with Myc-Cyfip. The 
Myc-Cyfip amount is too little to be visible on Ponceau red. 
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Immunoblotting with anti-Flag antibody enabled to identify 
Flag-tag proteins, whereas immunoblotting with anti-Myc 
permitted to assess the presence of Myc-Cyfip in complex with 
Flag-Nap1. 
Immunoblotting with anti-GST antibody shows that GST-
Sec6, but not GST-Exo70, specifically associated with Myc-Cyfip 
(Figure R3).  
Thus, Sec6 directly interacts in vitro with Cyfip (but not with 
Nap).  
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Figure R3. Cyfip interacts invitro with Sec6. GST-tag Exo70 
and Sec6 proteins were purified from E.Coli. Flag-tag proteins 
were purified from 293 cells. As negative control we used flag-
tag catalytically inactive Arno GEF (AEK). Immobilized Flag-tag 
proteins were incubated with soluble GST-Sec6 and GST-Exo70 
(soluble protein negative control) and isolated by centrifugation 
before analyzing bound material by SDS-PAGE. Ponceau red 
and Flag western blot show Flag-AEK and Flag-Nap. Myc 
western blot shows MycCyfip complexed with FlagNap. GST 
western blot shows GST-Sec6 interacting with MycCyfip. 5% of 
the input was loaded. 
 
1.1.4. WRC interacts in vitro with both Exo70 and Sec6 
The previous experiments demonstrated that direct 
interactions between isolated components of the WRC and exocyst 
complexes, namely Abi-Exo70 and Cyfip-Sec6, can be revealed 
using cell-free in vitro system and purified proteins. Next, we 
asked whether Abi1 and Cyfip can interact with the exocyst 
subunits also when engaged in the formation of the whole 
pentameric WRC complex, which represent the physiological 
relevant and biochemically active multiprotein unit. 
In order to achieve purification of the WRC complex, I 
exploited an efficient method recently published  that employs 
293T cells stably expressing various double tagged (Flag-HA) 
subunits of the WRC complex (Derivery et al., 2009).  
The steady-state expression level remains relative modest, 
similar to physiological conditions, because the WRC subunits are 
quickly degraded when not incorporated in whole WRC complexes. 
Since the exogenous Flag-HA tagged subunits are expressed at 
very high rate, they molecularly replace the endogenous ones in 
the WRC complexes and their excess is cleaned by the degradation 
cellular machinery. A single-step purification with anti-Flag 
antibodies allows to quickly obtain a partially pure WRC complex, 
95 
 
with a good stoichiometric ratio of the 5 subunits (Derivery et al., 
2009).  
I purified the WRC complex using 293T cell lines stably 
expressing Flag-HA double-tag Abi1 (isoform a) or Cyfip subunit. I 
incubated the cell lysates from these cell lines with beads coupled 
to Flag antibody, and I kept the purified WRC complex on beads 
for the subsequent assays (see Materials and Methods). As control 
cell line, I used cells expressing the Flag-HA-stop peptide only. 
The isolated WRC complex is nearly 90% pure as indicated 
by the coomassie staining, if we exclude the heavy-chain IgG band 
(Figure R4). Notably, Cyfip, Nap, Wave2 and Abi proteins are all 
present in the complex. Brick subunit (6 kDa) could not be 
detected under the conditions used because it runs out the gel due 
to its small molecular weight. Since based on previous evidence 
(Derivery et al., 2009) Brick is also part of the core WRC complex, 
we would expect Brick to be in the precipitates, but the use of 
different gels and of specific anti-Brick antibody wound be 
necessary to unequivocally make such statement. 
It is also of note that Abi1 is more abundant in the 
precipitates when its Flag-HA-tag version is expressed and used 
for purification of the whole WRC complex. This may be due to the 
fact that the Flag-HA-Abi1 is expressed at a level slightly exceeding 
that of the other endogenous components of the complex (Figure 
R7). The fraction of Abi1 not engaged into the WRC complex is also 
efficiently immunoprecipitated. 
 Immunoblotting analysis with specific antibody further 
confirmed the presence and the identity of the various components 
of the WRC complex, including Flag-HA-Cyfip/Cyfip, Nap, Wave2 
and Abi/Flag-HA-Abi. 
Note the difference in the molecular weight between the 
epitope-tag, exogenous and the endogenous proteins (Figure R4). 
Endogenous Cyfip runs faster than the double-tagged ectopically 
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expressed one due to the Flag-HA tags. In the case of Abi, however, 
endogenous Abi runs slower than the double-tagged one, 
presumably because a number of different Abi1 spliced isoforms 
with higher molecular weight are frequently expressed in 
mammalian cells. 
 
 
 
Figure R4. WRC complex purification. WRC was 
immunoprecipitated with immobilized anti-Flag antitbody from 
293 cells either stably expressing Flag-HA-stop as control, or 
Flag-HA-Cyfip or Flag-HA-Abi. Commassie staining of the 
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immunopurified complex resolved on SDS-PAGE shows Cyfip 
(130KDa), Nap (110KDa), Wave2 (70KDa) and Abi1 (55KDa) 
when the complex is immunoprecipitated using Abi subunit. The 
IgG heavy chain is indicated by §. Non-specific bands are 
indicated by *. Immunoblotting with anti-HA antibody shows the 
HA-tag proteins Cyfip and Abi. Note difference in molecular 
weight between tagged and untagged proteins in Cyfip and Abi 
western blots. The western-blots confirmed the presence and 
the identity of the various bands.  
 
In order to demontrate that GST-tag subunits Sec6 and 
Exo70 interact with Abi and Cyfip integrated into the WRC 
complex, I used the WRC complex purified and described upper. 
I incubated 1 hour this bead-bound purified WRC complex 
with soluble GST-Sec6 and GST-Exo70. I used soluble GST as 
negative control. Both GST-tag exocyst subunits, but not the GST, 
bound the WRC complex. Notably, the Flag-HA-stop peptide 
control did not show any binding neither to GST-Tag exocyst 
subunits, nor to GST (Figure R5). 
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Figure R5. The WRC Complex interacts in vitro with both 
Exo70 and Sec6. GST-Exo70 and GST-Sec6 proteins were 
purified from E.Coli, eluted and incubated with the WRC 
complex immunopurified as described in Figure R4. GST and 
Flag-HA-stop peptide were used as controls. Immunoblotting 
analysis with anti-GST antibody shows that GST-Exo70 and 
GST-Sec6 bind specifically to the Flag-HA immunopurified WRC. 
 
Collectively, these results indicate that the interaction 
between the WRC and the exocyst complexes is direct and 
presumably mediated by two independent protein:protein 
interaction pairs between  Abi::Exo70 and Cyfip::Sec6. These 
interactions can occur either when Abi and Cyfip are isolated or 
when they are integrated into the whole WRC complex. 
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1.2. WRC INTERACTS WITH EXOCYST IN VIVO 
To address whether the exocyst and WRC complexes 
associate in vivo, I performed co-immunoprecipitation experiments 
using 293T cells stably expressing epitope-tag subunits: Flag-HA-
Cyfip1 or Flag-HA-Abi1 for WRC, and His-V5-Sec6 for exocyst. The 
level of expression of exogenous proteins was comparable to that of 
the endogenous ones. It was reported (Derivery et al, 2009) that 
the epitope-tag Cyfip and Abi1 can replace the endogenous 
subunits in the WRC. I observed that the level of expression of the 
epitope-tag Sec6 was comparable to that of the endogenous one 
and that the endogenous Sec6 is not detectable anymore in the 
whole lysates of cells expressing His-V5-Sec5, suggesting that, also 
in the case of the exocyst, exogenous Sec6 can molecularly replace 
endogenous Sec6 and becomes integrated into the endogenous 
exocyst complex (Figure R6). Based on these considerations, our 
next strategy consisted in immunoprecipitating the exogenous, 
epitope-tag subunits, which are presumably incorporated into the 
corresponding complexes and test for proteins binding to these 
multimolecular units by immunblotting.  
 
1.2.1. Endogenous Cyfip co-immunoprecipitates with the 
exocyst complex 
I performed exocyst complex immonoprecipitation from 293 
cells stably expressing His-V5-Sec6. Immunoprecipitation with 
anti-V5 antibody pulled down, together with the most abundant 
epitope-tagged Sec6, other exocyst subunits, including Sec8, Sec5 
and Exo70. In fact, all the exocyst subunits we could test with 
available antibodies were present in the immunoprecipitates 
(Figure R6). The finding that the stoichiometry of the exocyst 
subunits is different from the expected one unit of each 
component per complex after Sec6-based purification is not 
surprising, considering that the exocyst is not a stable complex, 
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but its composition changes with spatio-temporal dynamics which 
are largely unknown (White and Camonis, 2005). 
I used two negative controls: anit-V5 immunoprecipitation 
from lysate of not-transfected 293 cells and immunoprecipitation 
with control IgG. 
Immunoblotting with anti-Cyfip antibody indicated that 
endogenous Cyfip protein specifically co-immunoprecipitates with 
the exocyst complex (Figure R6). 
 
 
 
Figure R6. Endogenous Cyfip co-immunoprecipitates with 
the exocyst. Exocyst V5 immunoprecipitation in 293 cells 
stably expressing His-V5-Sec6. The exocyst complex was 
immunoprecipitated with anti-V5 antibody as shown by Red 
Ponceau of proteins resolved by SDS_PAGE and the anti-Sec6, 
anti-Sec8, anti-Sec5 and anti-Exo70 immunostaining. Two 
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negative controls: V5 immunoprecpitation from not-transfected 
cells and IgG immunoprecipitation from His-V5-Sec6-expressing 
293 cells. Cyfip Western Blot shows a fraction of endogenous 
Cyfip co-precipitated with the exocyst complex. § These bands 
are the IgG heavy chains. * Non-specific bands. 
 
1.2.2. Endogenous Exo70 co-immunoprecipitates with the 
WRC   complex 
As previously described, I purified the WRC complex by 
performing anti-Flag immunoprecipitations from 293 cells stably 
expressing one epitope-tag subunit, either Flag-HA-Abi1, or Flag-
HA-Cyfip. 
Ponceau red staining of SDS-PAGE-resolved 
immunoprecipitates clearly shows the individal subunits of the 
WRC complex: Cyfip, Nap1, Wave2 and Abi (Brick exited from gels 
because of its small molecular weight). In these series of 
experiments, the stoichiometry of WRC complex resulted well 
preserved throughout the purification, with each subunit being 
present roughly at an equal molecular ratio.  
The staining with ponceau red revealed also the presence of 
non-specific bands at about 75 kDa and 55 kDa (the latter 
corresponding to IgG heavy chain)  
Immunoblotting analysis with specific antibodies enable to 
identify the various subunits of the WRC complex, Cyfip, Nap1, 
Wave2, Abi and Flag-HA-Abi (Figure R7), and Flag-HA-Cyfip 
(Figure R8).  
Remarkably, I found that endogenous Exo70 co-
immunoprecipitated with the WRC complex obtained either from 
Flag-HA-Abi or from Flag-HA-Cyfip expressing cells, but not from 
control Flag-HA expressing cells. 
Note that on whole cells lysates two bands of around 75 kDa 
are recognized by anti-Exo70 antibodies. Both bands, which 
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associate to the WRC complex, are specific since they disappeared 
after treatment with siRNA against Exo70 (Figure R10 B). 
The results of this set of experiment strongly suggest that 
Exo70 can interact with Abi even when this protein is integrated 
into into the WRC complex.  
 
 
 
Figure R7. Endogenous Exo70 co-immunoprecipitates 
with the WRC complex. Co-immunoprecipitation Flag-HA-
Abi - Exo70.  The WRC complex was purified by anti-Flag 
immunpecipitation as previously described. Ponceau red and 
westrern blots show the WRC complex subunits. Exo70 Western 
blot shows that endogenous Exo70 interacts specifically with 
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the WRC complex. The IgG heavy chain is indicated by §. Non-
specific bands are indicated by *. 
 
 
 
 
Figure R8. Endogenous Exo70 co-immunoprecipitates 
with the WRC complex. Co-immunoprecipitation Flag-HA-
Cyfip - Exo70.  The WRC complex was purified by anti-Flag 
immunpecipitation as previously described. Ponceau red and 
westrern blots show the WRC complex subunits. Exo70 Western 
blot shows that endogenous Exo70 interacts specifically with 
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the WRC complex. The IgG heavy chain is indicated by §. Non-
specific bands are indicated by *. 
 
1.2.3. The N-terminus of Abi1 mediates the interaction with 
Exo70 
The two-hybrid assay suggested that the N-terminus of Abi 
was responsible for the association with Exo70. In order to 
characterize which region of Abi1 interacts with Exo70 in vivo, I 
overexpressed HA-Exo70 alone or together with YFP-Abi full-length 
(Abi1FL, 1-476), YFP-Abi lacking N-terminus (Abi1DN, 145-476, or 
YFP-Abi N-terminus (Abi1N, 1-145) (Figure R9 A) in 293 cells. 
Next, I performed an immunoprecipitation using anti-YFP antibody 
and analyzed pulled-down proteins by anti-YFP and anti-HA 
immunoblotting.  
The different YFP proteins, including YFP alone that I used 
as control can be evidenced by immunoblotting with anti-YFP 
antibody. Immunoblotting with anti-HA antibody shows that HA-
Exo70 strongly associated with full-length Abi1, but more weakly 
with the Abi N-terminus. The very faint band detectable with 
AbiDN is comparable to the YFP control, indicating that AbiDN 
cannot interact with Exo70. These results indicate that the N-
terminus of Abi1 is required for binding to Exo70 and that the N-
terminus alone is sufficient for binding to Exo70, albeit with 
reduced affinity as compared to full-length Abi1 (Figure R9 B). 
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Figure R9. The N-terminus of Abi1 is required for binding 
to Exo70. (A) Diagram representing the various Abi1 and 
Exo70 constructs. HA-Exo70 and different YFP-Abi1 
fragments were used: full-length YFP-Abi1 (FL), YFP-Abi1 
deleted of its N-terminus (DN), and YFP-Abi N-terminus (N). (B) 
Co-immunoprecipitation YFP-Abi – HA-Exo70. Vectors 
expressing HA-Exo70 and YFP-Abi (FL, DN, N) or YFP as control, 
were cotransfected as indicated, then immunoprecipitation 
against YFP was performed.  
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2. FUNCTIONAL ROLE OF THE EXOCYST-WRC 
INTERACTIONS 
  
2.1. DEPLETION OF THE WRC OR EXOCYST SUBUNITS 
INHIBITS CELL MOTILITY OF HEK-HT CELLS IN WOUND-
HEALING ASSAY 
Our biochemical results show that WRC and exocyst 
complexes can associate in vivo, but also indicate that a minor 
fraction of the total complexes is engaged in the binding since only 
small amounts of Exo70 (Figure R7 and R8) and Cyfip1 (Figure R6) 
are recovered in the immunoprecipitations. 
We reasoned that the two complexes may interact in a 
temporal-limited and spatially-confined manner, and that their 
dynamic interactions may play some important roles in the 
regulation of cell motlity. We thus focus our investigation in trying 
to understand the function relevance of exocyst-WRC association 
in motile cells.  
To this end we used HEK-HT cells as motility model (Hahn et 
al., 1999). By performing wound-healing assays and single-cell 
tracking analysis, I firstly confirmed that both the WRC and 
exocyst complexes are required for HEK-HT motility. Depletion of 
all tested WRC (Abi1, Wave2, Cyfip1) or exocyst (Sec5, Sec6, Sec8, 
Exo70, Exo84) subunits  inhibited cell (Figure R10), under 
conditions in which no effects could be detected when RNAi oligos 
against unrelated proteins, such siLuc and siUSP9X (ubiquitin 
specific peptidase 9, X-linked) were used. 
An interesting implication of RalA in this cell line was 
surprising. In fact, RalB but not RalA was shown implicated in 
migration (Lim et al., 2006; Oxford et al., 2005; Rossé et al., 2006). 
This can be explained by cell specific effect, or 2D migration effect, 
or finally by a lower threshold in exerimpent results. 
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Figure R10. Depletion of WRC complex or the exocyst 
inhibits cell motility of HEK-HT cells in wound healing 
assay. (A) Depletion of Rals, exocyst or WRC inhibits 
wound healing cells motility. Graph is percentage of velocity 
reported to siLuc control. Depletion of RalA, RalB, Sec5, Sec6, 
Sec8, Exo70, Exo84, Abi1, Wave2, Cyfip1 inhibits cell migration 
in wound healing assay. Data from six independent 
experiments, from 20 to 125 cell per condition. Error bar is SEM. 
Student test **<0.001. (B)  Validation of protein depletions.  
 
 
2.2. THE EXOCYST IS REQUIRED FOR THE LOCALIZATION 
OF THE WRC COMPLEX AT THE LEADING EDGE OF MIGRATING 
CELLS 
108 
 
Localization of the WRC complex at the leading edges of 
lamellipodia to nucleate actin is crucial for migration. We therefore 
asked whether the exocyst is important for the localization of WRC 
complex at the leading edge of migrating cells by depleting 
individually various exocyst subunits (Sec5, Sec6 or Exo70). For 
these experiments we used random motile HEK-HT cells on 
fibronectin substrate. 
In control siLuc-treated cells, Wave2 is prominently and 
specifically localized at the tips of lamellipodia, which occupy the 
majority of the cell periphery (Figure R11 A).  
To quantify Wave2 recruitment at the leading edges, I used 
Image J software to manually draw and measure the total cell 
outline (a) and the outline portions positive for Wave2 staining (b). 
The b/a ratios represent the “% of cell outline with Wave2”.    
71% of the outline of motile control cells presented 
recruitment of Wave2. However, When I depleted exocyst subunits 
(Sec5, Sec6 or Exo70), the percentage significantly decreased 
(Figure R11 B). Importantly, the depletion of these exocyst 
subunits did not change the total cell outline (Figure R11 C). 
These results support the hypothesis of a critical role of the 
exocyst in the recruitment of the WRC complex to the leading edge 
of cell protrusions.  
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Figure R11. Functional studies of exocyst-WRC complexes 
interaction.  
(A) Exocyst is required for Wave2 localization at the front 
of migrating cells. (A) Wave2 immunofluorescence on 
random-motile HEK-HT cells. Representative photos of 
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Wave2 staining of migrating HEK-HT cells, depleted or not of 
exocyst subunits. (B) Quantification of Wave2 recruitment 
at the cell outline. The percentage of perimeter of the cell with 
positive staining for Wave2 was measured. Data from three 
independent experiments, ten cells per condition. (C) 
Quantification of the cell outline of cells lacking the 
exocyst. Error bar is SEM. Student test **<0.001. 
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CHAPTER 3: 
MOLECULAR AND 
FUNCTIONAL LINKS BETWEEN 
EXOCYST AND RAC VIA 
SH3BP1 
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1. THE RHOGAP SH3BP1 ASSOCIATES WITH THE EXOCYST   
The two-hybrid screening had suggested a potential 
interaction between the N-terminal BAR domain of SH3BP1 and 
two exocyst subunits, Sec8 and Exo84. In order to verify whether 
SH3BP1 indeed associated in vivo with exocyst, I used a co-
immunoprecipitation approach from 293T cells.  
Since I could not succeed in co-immunoprecipitating 
endogenous exocyst subunits with endogenous SH3BP1, I had to 
overexpress at least one partner. 
Overexpressed full-length SH3BP1 co-immunoprecipitated 
with endogenous Sec8. This interaction resulted to be mediated by 
BAR domain. In fact, when I used SH3BP1 deleted of the BAR 
domain, the interaction was abolished (Figure R12 B). This result 
is coherent with the two-hybrid data. 
Moreover, by overexpressing Sec8 or Exo84 with full-length 
SH3BP1 or with SH3BP1 truncated of its C-terminus, I could show 
an interaction of both exocyst subunits with both SH3BP1 forms. 
Overexpressed Sec8 or Exo84 did not interact with SH3BP1 
lacking the BAR domain (Figure R12 C and D).  
In conclusion, both two-hybrid screen and co-
immunoprecipitation experiments demonstrated that SH3BP1 
binds to Sec8 and Exo84, and that this interaction is mediated by 
SH3BP1 BAR domain.  
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Figure R12. The RhoGAP SH3BP1 associates with the 
exocyst. (A) The three DNA SH3BP1 constructs used. Full-
length wild-type SH3BP1 (wt), SH3BP1 lacking BAR domain 
(DBAR) and lacking C-terminus (DCter). (B) Endogenous 
exocyst interacts in vivo with SH3BP1. Vectors expressing 
SH3BP1 wt or SH3BP1 DBAR were transfected in 293T cells. 
Endogenous Sec8 was co-immunoprecipitated with anti-Sec8 
antibodies covalently linked to beads. Upper western blot shows 
associated SH3BP1. (C) SH3BP1 co-immunoprecipitates 
with Exo84. Vectors expressing HA-tagged Exo84 and SH3BP1 
(wt, DBAR, or DCter) were transfected into 293T cells. Exo84-HA 
was immunoprecipitated with anti-HA antibodies, and 
associated SH3BP1 was detected by western blotting. (D) 
SH3BP1 co-immunoprecipitates with Sec8. Vectors 
expressing HA-tagged Sec8 and SH3BP1 (wt, DBAR, or DCter) 
were transfected into 293T cells. Sec8-HA was 
immunoprecipitated with anti-HA antibodies, and associated 
SH3BP1 was detected by western blotting.  
 
 
2. SH3BP1 LOCALIZES AT THE EDGE OF MIGRATING CELLS, 
TOGETHER WITH THE EXOCYST 
2.1. SH3BP1 LOCALIZES AT THE LEADING EDGE 
We were interested about localization of SH3BP1 in motile 
cells. I used normal rat kidney (NRK) cells in immuno-fluorescence 
experiments. Cell motility was induced by producing with a pipette 
tip a scratch in the confluent cell monolayer (wound-healing 
assay). By wide-field microscopy, I found that SH3BP1 localized at 
the advancing front of lamellipodia in control cells. This staining at 
the leading edge was specific because it disappeared in cells 
depleted of SH3BP1 and it was reproducible using three different 
antibodies (Figure R13 A). This localization of SH3BP1 at the front 
by immuno-fluorescence was also confirmed by confocal 
microscopy (Figure R13 C).  
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2.2. SH3BP1 COLOCALIZES AT THE LEADING EDGE WITH 
THE EXOCYST 
We then studied the colocalization of SH3BP1 and exocyst. I 
performed double staining on NRK cells: SH3BP1 and Sec8 or 
Exo84. Confocal analysis showed that SH3BP1 is enriched at the 
same cellular locations as Sec8 or Exo84:  the leading edges of 
lamellipodia (Figure R13 C).  
 
2.3. SH3BP1 AND EXOCYST LOCALIZATIONS AT THE 
FRONT ARE MUTALLY DEPENDENT 
We studied the effect of depletion of exocyst on SH3BP1 
localization at the front, and viceversa. On one side, depletion of 
Sec8, Exo84 and Sec5 subunits by RNAi reduced SH3BP1 
localization at the leading edge of migrating NRK (Figure R13 B). 
On the other side, depletion of SH3BP1 reduced recruitment of 
exocyst to the leading edge, Sec8 subunit in this experiment 
(Figure R13 D). This indicates that both SH3BP1 and exocyst are 
important for the localization of each other at the front of 
migrating cells. 
 
2.4. THE BAR DOMAIN OF SH3BP1 IS REQUIRED FOR ITS 
RECUITEMENT TO THE FRONT 
Exogenous full-length SH3BP1 localized at the front as the 
endogenous SH3BP1 (Figure R13 E). SH3BP1 lacking the BAR 
domain was not recruited to the front (Figure R13 E and F). This 
suggests that the BAR domain, presumably via its interaction with 
the exocyst, is important to the transport of SH3BP1 to the front. 
These results all together are supporting the notion that SH3BP1 
associates with the exocyst at leading edge of migrating cells, 
where SH3BP1 may play a role locally in the regulation of 
migration. 
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Figure R13. SH3BP1 Localizes at the Front of Motile Cells, 
Together with the Exocyst. 
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(A) SH3BP1 localizes at the front. Immuno-fluorescence 
staining for SH3BP1 was made on motile control or SH3BP1-
depleted NRK cells. NRK cells were fixed during migration, and 
stained with one of three different antibodies against SH3BP1 
(two commercial antibodies were bought from Everest Biotech 
and Atlas Antibodies; one home-made antibody was a gift from 
Dr. P. Cicchetti). Representative images show the result of 3 to 4 
independent experiments. Graphs on the right show 
quantification of these experiments (mean percentages of cells 
showing SH3BP1 signal at leading edge; 100 cells per condition 
per experiment). Control is siRNA targeting Luciferase. Cicchetti 
antibody gives nonspecific nuclear signal. (B) Effect of exocyst 
or SH3BP1 depletion on SH3BP1 recruitment to the front. 
NRK cells were treated with siRNA targeting SH3BP1 
(siSH3BP1-2) or exocyst subunits, fixed during migration and 
stained for SH3BP1. Graph shows percentage of cells having 
signal at the front. This quantification comes from 2 to 6 
independent experiments (100 cells per condition per 
experiment). (C) SH3BP1 colocalizes with Exo84 and Sec8. 
Migrating NRK cells were costained for SH3BP1/Sec8 and 
SH3BP1/Exo84. On the right confocal microscopy merged 
images, generated using ImageJ software (NIH). (D) SH3BP1 
depletion disturbs exocyst localization. Migrating NRK cells 
were depleted of SH3BP1 and stained for Sec8. Graph shows 
quantification of 3 independent experiments. (E) BAR domain 
is required for SH3BP1 localization at the front. Vectors 
expressing SH3BP1 wt or SH3BP1 DBAR were transfected into 
NRK cells, cells were stained for SH3BP1. Stars indicate 
transfected cells overexpressing SH3BP1 proteins. Arrows 
indicate endogenous or exogenous SH3BP1 signal at the front. 
(F) Quantification of experiments in (E). Quantification of 
three independent experiments. Bars on images indicate 10 um. 
Bars on graphics represent SEM. * indicates p < 0.05, **p < 
0.01, and ***p < 0.001 (Student’s t test).  
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3. SH3BP1 REGULATES CELLS MOTILITY  
We investigated the functional implication of SH3BP1 in cell 
migration using wound healing assay. For quantitative read out of 
the role of SH3BP1 in migration, we used single cell-tracking 
analysis.  In NRK cells, I efficiently depleted SH3BP1 via two 
independent siRNAs (Figure R15 C) and measured single cell 
velocity. Cell-tracking analysis showed that the speed of cell 
migration during wound closure was reduced by 30%–45%. It 
revealed also a slight but significant (10%–15%) decrease in 
persistence of migration (Figure R14).  
We tested another in vitro migration assay, the Boyden 
chamber. Consistently with wound-healing assay results, it 
showed that cells lacking SH3BP1 cannot migrate. This migration 
defect was corrected by overexpressing the human form of SH3BP1 
that is resistant to the SH3BP1 siRNA (see Supplemental article, 
Figure 3D).  
This rescue of normal migration phenotype was obtained 
also in wound healing assay, by tracking cells expressing cherry-
fused alleles of SH3BP1, in a SH3BP1-depleted or normal context. 
Cells depleted of endogenous SH3BP1 and expressing a siRNA-
resistant SH3BP1 could migrate normally. But expression of a 
SH3BP1 R312A mutant, which impairs the GAP activity of 
SH3BP1, did not rescue migration. This indicates that the GAP 
activity of SH3BP1 is required for its function in regulating cell 
migration. Interestingly, neither the expression of SH3BP1 DBAR 
rescued cell migration. This shows that also the BAR domain is 
important for SH3BP1 function in cell migration (see Supplemental 
article, Figure 3E). 
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Figure R14. SH3BP1 regulates cell motility. Single cell-
tracking analysis. Cell velocity and migration persistency were 
measured by cell tracking from 3 independent wound healing 
experiments, using ImageJ software. (p values are results of Student’s 
t test). 
 
4. RALB, EXOCYST AND SH3BP1 DO NOT CONTROL 
ORIENTATION OF MICROTUBULES ORGANIZING CENTER  
It was shown by in vitro assays that RhoGAP domain of 
SH3BP1 has a GAP activity on Cdc42 and Rac1, but not RhoA 
(Cicchetti et al, 1995). We wanted to know whether in vivo, in 
migrating cells, SH3BP1 has a GAP activity on Rac or Cdc42 or 
both. During migration, microtubule-organizing center (MTOC) 
and Golgi apparatus reorient to face the wound. This phenomenon 
is controlled by Cdc42 (Ridley et al, 2003, Etienne-Manneville, 
2004). Depletion of the RhoGEF b-Pix, a well-known activator of 
Cdc42 (but also of Rac in some circonstances), inhibits this 
reorientation of MTOC (Osmani et al, 2006).  
I performed MTOC repositioning experiments in migrating 
cells. Depletion of b-Pix inhibited MTOC reorientation, as expected. 
However depletion of either RalB, different exocyst subunits (Sec5, 
Sec8, Exo84) or SH3BP1 did not disrupt MTOC positioning face to 
the wound (Figure R15 A). This shows that the 
RalB/exocyst/SH3BP1 pathway does not regulate cell migration 
by controlling MTOC reorientation, and that it does not control 
Cdc42 activity in migrating cells.  
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Moreover, overexpression of SH3BP1 DBAR, that cannot 
bind exocyst, did not disturb MTOC reorientation (Figure R15 B), 
meaning that interaction with exocyst is not the determinant for 
SH3BP1 to choose Rac instead of Cdc42. As positive controls in 
this experiment, I expressed dominant-negative (N17) or 
dominant-active (V12) Cdc42 mutants, which both perturbed 
MTOC positioning as expected. 
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Figure R15. RalB, exocyst or SH3BP1 do not control 
Microtubule-Organizing Center orientation during 
migration. (A) RalB, exocyst or SH3BP1 depletions do not 
disturb Microtubule-Organizing Center orientation. On the 
left, a representative photo of well oriented MTOC in a migrating 
cell (MTOC should be into an angle of 120 degrees). The MTOC 
was stained with anti-pericentrin antibodies, the nucleus with 
DAPI, and the actin fibers with phalloidin. On the right, 
quantifiation of MTOC orientation in migrating cells depleted 
with siLuc (control), sibPix, siRalB, siSec5, siSec8, siExo84, 
siSH3BP1-1, or siSH3BP1-2. 3 independent experiments, 100 
cells per condition per experiment). (B) Expression of wild-type 
SH3BP1 or DBAR mutant does not perturb MTOC 
orientation. Exogenous wild-type SH3BP1 (wt), SH3BP1 
DBAR, dominant-negative Cdc42N17 or dominant-active 
Cdc42V12 were expressed into NRK cells. Quantification was 
only on cells expressing exogenous proteins, which were 
identified by costaining with anti-SH3BP1 or anti-Cdc42 
antibodies. Error bars represent SEM. ** indicates p < 0.01 
(Student’s t test). (C) Validation of Protein depletions. NRK 
cells were treated with the indicated siRNA (siLuc, siSH3BP1-1, 
siSH3BP1-2, siβPIX, siRalB, siSec5, siSec8 or siExo84). A 
portion of cells were used for wound-healing or MTOC 
experiments, the rest were lysed and analyzed by western blot 
with the indicated antibodies. 
 
 
5. SH3BP1 CONTROLS THE ORGANIZATION OF CELL 
PROTRUSIONS BY INACTIVATING RAC AT THE FRONT 
A series of additional experiments performed in our group 
showed that the target of SH3BP1 in migration is Rac. 
A FRET approach with Raichu biosensors (tools to monitor 
the spatiotemporal activation of Rac1 in living cells) was used to 
study the gradient of Rac activity at the front of motile cells (see 
Supplemental article, Figure 5A and Movie S2). Quantification of 
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Rac activity along a line in the direction of cell movement, from the 
nucleus to the leading edge, showed that the Rac1 gradient is 
significantly up-regulated when SH3BP1 is depleted (see 
Supplemental article, Figure 5C). We concluded that SH3BP1 is 
required to inactivate Rac1 at the front. 
Since Rac1 activity regulates the formation of protrusions 
(Pankov et al, 2005; Raftopoulou and Hall, 2004; Ridley et al, 
2003), we asked whether abnormally up-regulated Rac1 activity 
has an impact on protrusion dynamics in SH3BP1-depleted cells. 
Visualization of cell outlines of migrating cells showed that 
depletion of SH3BP1 induced delocalized and more numerous 
lamellipodia, leading to an efficient migration (see Supplemental 
article, Figure 6A and Movie S3). Computer-assisted analysis of 
morphodynamics demonstrated that the protrusions of migrating 
cells lacking SH3BP1 developed more rapidly but were more 
unstable, as compared to those of control cells (see Supplemental 
article, Figures 6C-H). We concluded that SH3BP1 is necessary for 
the spatiotemporal organization of protrusions during cell 
migration.  
Importantly, both Rac activity up-regulation and protrusion 
disorganization in SH3BP1-depleted cells could be rescued by 
expression of siRNA-resistant wild-type SH3BP1, but not of the 
R312A GAP-defective mutant, strongly supporting the function of 
SH3BP1, via its GAP activity on Rac, in the spatiotemporal 
regulation of protrusions during cell motility. 
Cells expressing GTP-hydrolysis-deficient RacG12V 
presented defects in motility and morphodynamics (see 
Supplemental article, Figures 7A-C). So, overexpression of active 
Rac1 mimics depletion of SH3BP1. Inactivation of Rac at the right 
moment and at the right place is crucial for formation of efficient 
lamellipodia.  
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DISCUSSION 
RalB/exocyst pathway participates to cell migration (Lim et 
al., 2006; Oxford et al., 2005; Rossé et al., 2006). WRC complex is 
an important actor in cell migration by promoting downstream of 
Rac actin branch elongation and thus generating dendritic 
network supporting lamellipodia extension (Amann and Pollard, 
2001; Takenawa and Miki, 2001). However, how RalB/exocyst and 
Rac/WRC pathways are coordinated during cell migration was still 
elusive at the beginning of my PhD. 
To shed light on this question, I have studied the molecular and 
functional links between RaB/exocyts and Rac/WRC, which 
emerged from screenings previously performed in our laboratory. 
 
 
 
Figure D1: Summary of the cross-talk between Ral and 
Rac pathways in the control of cell migration. 
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1) THE SH3BP1 LINK 
We demonstrated by several biochemical approaches that 
the exocyst associates with SH3BP1 and that this interaction is 
mediated by SH3BP1 BAR domain, confirming and validating the 
two-hybrid screening data.  
In motile NRK cells, SH3BP1 is localized at the leading edge 
of cell protrusions (Figure R12 A and C), where also Sec8 or Exo84 
are present (Figure R12 C). More relevantly, SH3BP1 localization 
depends on exocyst and conversely exocyst localization depends on 
SH3BP1 (Figure R12 B), indicating the importance of the 
interaction between SH3BP1 and the exocyst for their recruitment 
at the front of migrating cells. 
Depletion of SH3BP1 decreases cell velocity (Figure R14 A 
and Figure R15 C), a defect that can be rescued by the Expression 
of a wild-type SH3BP1 form resistant to siRNAs, but not by the 
expression of GAP-deficient or BAR-deleted SH3BP1 (see article, 
Figure 3 D and E). This latter finding indicates that the GAP 
activity and the BAR domain of SH3BP1 are both important for 
migration. 
The BAR domain is necessary for SH3BP1 binding to 
exocyst, for the localization of SH3BP1 at the front (Figure R13 E 
and F) and for SH3BP1 function in motility regulation. Thus, the 
BAR domain by its binding to exocyst, plays a critical role in 
SH3BP1 recruitment to the cell leading edge.  
We proposed a model in which the exocyst recruits the 
RhoGAP SH3BP1 to the extending lamellipodia, where it may act 
locally as a GAP on RhoGTPases, to regulate cell migration.  
Next, we had to identify the Rho-family target of SH3BP1 in 
motile cells. 
Previous in vitro works had shown that the RhoGAP domain 
of SH3BP1 has GAP activity toward Cdc42 and Rac1, but not RhoA 
(Cicchetti et al, 1995). The fact that front-rear polarity, assessed 
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by the study of microtubule-organizing center (MTOC), is not 
perturbed by depletion of SH3BP1 (Figure R15 A), suggested that 
Cdc42 is not the likely target of SH3BP1 gap activity, leaving Rac1 
as the most probable SH3BP1 substrate. 
Interestingly, Ral/exocyst/SH3BP1 pathway regulates 
migration not by regulating cell polarity, but by controlling the 
directionality of migration. In fact, SH3BP1-depleted cells have 
persistency defects (Figure R14). 
The final proof that Rac1 is indeed the target of SH3BP1 in 
motile cells came from the direct observation of localized Rac 
activity using a FRET-based Rac1 biosensor. I found that in 
SH3BP1 depleted cells, Rac1 activity is significantly up-regulated 
at the leading edge (see article, Figure 5C), but not in other parts 
of the cell. This result indicates that SH3BP1 is required to 
inactivate Rac1 at the leading edge. 
Collectively, our data led us to propose the following model: 
the exocyst complex interacts with the RhoGAP SH3BP1 in order 
to transport it to the leading edge of lamellipodia where SH3BP1 
may encounter and inactivate its target Rac1-GTP (Figure D2). 
Many GEF proteins, have been proposed to mediate Rac 
activation at the leading front of migrating cells, these include 
bPIX (ten Klooster et al., 2006), DOCK3 (Sanz-Moreno et al., 2008), 
Asef (Itoh et al., 2008), and Tiam1 (Palamidessi et al., 2008). In 
particular, this latter work proposed that Rac activation may occur 
on endosomes. Endosome-localized and activated Rac may than 
translocate to the plasmamembrane via recycling contributing to 
spatial restriction and polarization of Rac signaling.  
The presence of a GAP at the front is somewhat 
counterintuitive since activation rather than inactivation of this 
GTPases is expected to be critical to initiate and/or sustain 
signaling, leading to actin polymerization. However, this finding 
can be conceptualized assuming that a constant and spatially-
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restricted turnover of Rac activity is required to properly regulate 
the dynamics of protrusions and adhesions during migration. 
Indeed, a number of reports indicates that the expression of 
constitutive active Rac promotes isotropic extension of lamellipodia 
and stabilizes focal adhesion, but inhibit directional motility, 
lending support to the notion that temporal and polarized 
activation of Rac is the critical event to sustain cell locomotion. 
Within this context, SH3BP1 may be an intrinsic component of a 
Rac built-in regulatory system aimed at promoting successive 
cycle of activation of Rac through localized delivery of both 
guanine nucleotide exchange factors as well as of GAP. 
 
 
 
 
Figure D2: Model of exocyst-mediated recruitment of 
SH3BP1 to the leading edge, and inactivation of Rac at 
the front. 
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1) EXOCYST AND WRC BIOCHEMICAL INTERACTION 
 
We found that two protein::protein interactions, Abi1::Exo70 
and Cyfip::Sec6, mediate a direct association between the WRC 
and the exocyst complexes. Abi and Cyfip were found to interact 
with exocyst components both as free isolated proteins (Figure R2 
B and R3) and as subunits integrated into the WRC complex 
(Figure R5). 
We could roughly map the putative Exo70-binding interface 
on a region encompassing amino acid 36-145 of Abi by combining 
two-hybrid and co-immunoprecipitation data, However, the 
isolated N-terminus domain alone of Abi1 (aa 1-145) interacted  
with an apparent very low affinity with Exo70. This result suggests 
that other portions of the Abi protein likely contribute to Exo70 
binding, or that additional Abi1-binding partners facilitate 
interaction with Exo70. 
We further demonstrated the in vivo relevance of the 
interaction between exocyst and WRC by using cell lines stably 
expressing, at physiological level, an epitope tagged component of 
the WRC complex (Figure R7, R8 and R9). In the case of WRC 
complex, the immunoprecipitation shows the presence of all five 
components because the WRC complex is constitutive and stable 
(Gautreau et al., 2004), whereas the immunoprecipitation of the 
exocyst complex does not show all the subunits because the 
exocyst is much more dynamic, it is composed of at least two 
subsets, one on secretory vesicles and one as a secretion target on 
the plasma membrane (Guo et al., 2000; Guo et al., 1999 ; Guo et 
al., 1999b, Moskalenko et al,. 2003). This explains the  
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2) FUNCTIONAL ROLE OF EXOCYST-WRC INTERACTION 
 
We found that Ral proteins, exocyst and the WRC complex 
are all implicated in migration of HEK-HT cells (Figure R10 A).  
The implication of RalA in the migratory properties of this 
cell line was surprising. In fact, using other cell models, RalB but 
not RalA was shown to affect cell migration in other cell types (Lim 
et al., 2006; Oxford et al., 2005; Rossé et al., 2006). This could be 
due to a cell type specific effect. 
The inhibitory effect on cell velocity (roughly 30 %) was 
similar for depletion of RalB and of most of exocyst subunits, with 
the notable exception of Exo70 the depletion of which resulted in a 
more marked inhibition of cell motility. Importantly, these effects 
were observed despite exocyst depletions was significant (~ 50 %), 
but never complete, suggesting that the amount of the core 
exocyst components is limiting for migration. It is of note that we 
could not assess whether exocyst is absolutely required for cell 
migration since the complete silencing of exocyst led to cell 
toxicity.  
The impact of WRC and Exo70 depletion was stronger 
(roughly 60 % velocity inhibition). The more drastic inhibition of 
cell migration observed after Exo70 depletion might be due the fact 
that this protein, which is not part of the core exocyst complex, 
was shown to directly interact with Arp2/3 complex (Zuo et al., 
2006) and/or with Abi. Notably, in yeast, Exo70p does not seem to 
be associated to vesicles, but it is stably localized at the 
plasmamembrane (Boyd et al., 2004). The stable position of the 
subunit Exo70 of the exocyst suggests that it may act as docking 
device for the delivery of vesicles. A similar situation may also 
occur in mammalian cells. In this system, thanks to its interaction 
with Phosphatidylinositol, Exo70 is crucial for the docking and 
fusion of post-Golgi secretory vesicles to the plasma membrane 
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(Liu et al., 2007). These peculiar features may account for the 
more essential role exerted by Exo70 on cell migration as 
compared to other exocyst components.  
We studied the relation between exocyst and WRC 
localization at the leading edges of lamellipodia. It is generally 
accepted that if WRC is present at the edge this means that it is 
active. The molecular mechanisms accounting for the activation of 
WRC at this location have been recently clarified using 
biochemical Lebensohn and Kirschner, 2009) and structural 
approaches (Chen et al., 2010). The emerging model indicates 
WRC activity is the result of a set of integrated protein::protein and 
protein::lipid interactions, which concur in the proper modulation 
of WRC activation. Within this context binding of WRC to active 
Rac, its phoshorylation as well its association with plasma 
membrane localized PIP3 appears to act in synergy in promoting 
full, but spatially restricted activation of the complex at the 
plasmamembrane. Conversely, little remains known about the 
molecular mechanisms that bring the WRC complex to the 
plasmamembrane. Even though it has been proposed that active 
Rac may be sufficient to recruit the WRC complex to the 
plasmamembrane to promote actin branching (Miki et al., 1998; 
Steffen et al., 2004), other factors are very likely involved. 
Consistently, we found that the recruitment of Wave2 at the 
leading edge of random migrating cells is impaired in the absence 
of the exocyst (Figure R11 A and B), suggesting a role of exocyst, 
beside Rac, in directing the WRC at the sites of its action. We are 
currently repeating these experiments in a context of Rac 
activation (cells expressing RacV12), both in non migrating cells 
(HeLa) and in random motile cells (HEK-HT), in order to better 
characterize the respective contribution of Rac-GTP and of exocyst 
in WRC recruitment.   
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Overall our results are consistent with the model of exocyst 
working as carrier of WRC: the exocyst complex interacts with the 
WRC in order to transport it to the leading edge of lamellipodia 
where WRC can meet its activator Rac1-GTP (Figure D3). 
 
 
 
 
 
Figure D3: Model of exocyst mediated recruitment of WRC 
complex to the leading edge, in order to be activated by 
Rac-GTP and to promote actin branching. 
 
According to this simple, yet speculative model, the exocyst 
may contribute to drive WRC to the leading edge, where it can bind 
to and become activated by Rac (via Cyfip). Activated, GTP-loaded 
Rac may subsequently trigger the dissociation of the exocyst-WRC 
interaction, freeing the exocyst for another round of transport. If 
the model if correct, we would expect that the WRC complex is 
unable to interact at the same time with both exocyst and active 
Rac. To validate this prediction, we are currently performing in 
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vitro competition experiments with purified proteins. Most 
specifically, we are testing whether the WRC-GSTSec6 association 
can be disrupted by adding purified active RacV12, but not 
inactive RacN17.  
To further validate the relevance of our model, we also plan 
to perform live imaging experiments with fluorescent constructs of 
exocyst (Cherry-Exo70, Cherry-Sec6) and of WRC complex (GFP-
Wave2, GFP-Abi1, GFP-Nap1 and GFP-Cyfip1). On one side, fast-
acquisition video-microscopy will provide us with spatial-temporal 
information about the coordinated dynamics of these proteins. On 
the other side, fluorescence-lifetime imaging microscopy (FLIM) will 
be used to try to directly visualize in live motile cells the molecular 
interactions between exocyst and WRC complexes.  
 
 
2) EXOCYST, AN ORGANIZER OF RAC PATHWAY  
 
Our data add on the a set of emerging evidence which 
indicates that the exocyst complex is involved in many biological 
processes that require the targeting and tethering of vesicles to 
specific plasma membrane domains (Whyte et al., 2002; Lipschutz 
et al., 2002). One example is protrusion formation during 
migration. In fact, migrating cells need to establish a leading front, 
enriched by trafficked components important for lamellipodia 
extension (Hertzog and Chavrier, 2011).  
The exocyst may be more than a structural multi-molecule 
entity helping the transport of vesicles to the plasmamembrane, it 
might be actively implicated in signaling by recruiting to 
lamellipodia important regulatory molecules, thus impacting on 
migration.  
Strikingly, the exocyst appears to be linked to both 
downstream and upstream Rac pathways, acting on the one hand 
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on a Rac negative regulator, such as SH3BP1, a GAP specific for 
Rac at the cell leading edge, and on the other hand on a Rac 
effector (WRC complex). Exocyst may be essential to orchestrate a 
regulatory loop centered on Rac: activated Rac will switch on the 
WRC complex to promote actin branching and it will be inactivated 
by SH3BP1 (Figure D4). 
 
 
 
Figure D4: Integrative model of exocyst-mediated double 
recruitment of Rac regulator (SH3BP1) and Rac effector 
(WRC complex) to control motility at the leading edge.  
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5) PERSPECTIVES 
 
This PhD work established the existence of a direct 
association between a major complex regulating exocytosis, the 
exocyst, and a major complex regulating actin dynamics, the WRC 
complex. In order to investigate in more detail the relevance of this 
novel association, in a variety of cellular functions, a very powerful 
tool would be the availability of mutants that disrupt specifically 
protein::protein association without perturbing the integrity and 
functionality of the whole complex.  
Among the two complexes, the exocyst does not seem to be a 
good candidate in order to search for WRC-binding-deficient 
mutations. The exocyst is a dynamic complex, having different 
subunit composition depending on the biological process. 
Furthermore, crystal structures are solved only for portions of 
some of the subunits, but we are still far from the solution of the 
tertiary structure of whole exocyst complex. Conversely, the WRC 
complex seems to be a better candidate to identify specific 
mutation impairing the biding to the exocyst. The WRC complex is 
constitutive, very stable, and its crystal structure has been 
recently solved (Chen et al., 2010).  
It remains to be established whether we need to identify 
interaction-impaired mutant of Cyfip or Abi1. Cyfip is a high 
molecular weight protein, relatively unstable. Furthermore, Cyfip 
minimal interaction domain with Sec6 defined by two hybrid assay 
is rather extended. Abi1 instead is a better characterized protein, 
relative stable even when isolated from the complex, and easier to 
manipulate than Cyfip. Moreover, Abi1 interaction domain with 
Exo70 was better defined both by two-hybrid assay and by co-
immunoprecipitation experiments: it is the N-terminus region 
comprising the aa 36-145.  
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Furthermore, the structure of almost the entire Exo70 
subunit, the Abi partner, is solved. In fact, structures of 62–623aa 
and 58–543aa yeast Exo70 (Dong et al., 2005; Hamburger et al., 
2006) and of 85–653aa mouse Exo70 Moore et al., 2007) are 
available. In mutation design and analysis, we will need to keep in 
mind that Exo70 has distinct cell behavior comparing to the other 
exocyst components. Exo70 localizes at plasmamembrane (Boyd et 
al., 2004; He et al., 2007), and interacts with the PIP2 (Liu et al., 
2007), and even Arp2/3 complex (Zuo et al., 2006), beside Abi.  
By carefully comparing the Abi and Exo70 structures and by 
modeling potential binding interfaces, we plan to rationally design 
several mutations of Abi residues that interfere with Abi binding to 
Exo70 but not with its incorporation into the WRC complex. If the 
in silico analysis cannot be narrow enough to identify single 
aminoacid but only sequences, random mutagenesis by error-
prone DNA polymerase may be performed on selected Abi 
sequences.   
Thus, this Exo70-binding-deficient Abi mutant should still 
incorporable into WRC complex but should not bind anymore the 
exocyst complex.  
The candidate mutations will be tested as follows. First, we 
will test by two-hybrid assay whether the Exo70-binding-deficient 
Abi mutants can bind Wave2, but not Exo70. Second, we will test 
the incorporation of the Exo70-binding-deficient Abi mutants in 
the WRC by co-immunoprecipitation strategies similar to those 
shown in Figures R6, R7 and R8. 
The availability of Exo70-binding-deficient Abi mutants will 
allow us to ask important questions on the role of exocyst-WRC 
association. 
 In the context of cells depleted of endogenous Abi, we will 
able to compare the functional effect on migration, and also on 
other biological processes, of expression of a Exo70-binding-
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deficient Abi mutant   with respect to the expression of wild-type 
Abi.  
We will construct GFP-fusion of this Abi mutant, whose 
localization will be compared to that of GFP-Abi wild-type. This 
construct will be also used in two parallel live imaging approaches: 
fast-acquisition video-microscopy and fluorescent life time imaging 
microscopy (FLIM). By combining the use of this Abi mutant 
molecular tool together with powerful imaging techniques, we are 
expected to learn a lot on when, where, how and why the exocyst 
and WRC complexes meet inside the cells.  
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